The	O
promoter	B-DNA
and	O
5	B-DNA
'	I-DNA
flanking	I-DNA
sequences	I-DNA
controlling	O
human	O
B29	B-DNA
gene	I-DNA
expression	O
.	O

The	O
product	O
of	O
the	O
B-cell-specific	B-DNA
B29	I-DNA
gene	I-DNA
(	O
B29	B-protein
,	O
Ig	B-protein
beta	I-protein
,	O
CD79b	B-protein
)	O
is	O
essential	O
for	O
Ig-mediated	O
B-cell	O
activation	O
via	O
the	O
B-cell	B-protein
antigen	I-protein
receptor	I-protein
complex	I-protein
(	O
BCR	B-protein
)	O
on	O
human	B-cell_type
and	I-cell_type
murine	I-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

To	O
better	O
understand	O
the	O
regulation	O
of	O
this	O
pivotal	O
gene	O
,	O
we	O
have	O
analyzed	O
the	O
human	B-DNA
genomic	I-DNA
DNA	I-DNA
sequence	I-DNA
upstream	O
of	O
the	O
B29	B-protein
ATG	B-DNA
start	I-DNA
codon	I-DNA
for	O
transcriptional	O
control	O
activity	O
.	O

The	O
human	O
B29	B-DNA
gene	I-DNA
lacks	O
either	O
a	O
TATA	B-DNA
or	I-DNA
a	I-DNA
CAAT	I-DNA
box	I-DNA
and	O
transcription	O
is	O
initiated	O
at	O
multiple	B-DNA
sites	I-DNA
.	O

The	O
minimal	O
promoter	O
of	O
the	O
human	B-DNA
B29	I-DNA
gene	I-DNA
is	O
contained	O
within	O
a	O
193-bp	B-DNA
region	I-DNA
5	O
'	O
of	O
these	O
multiple	B-DNA
start	I-DNA
sites	I-DNA
.	O

This	O
minimal	B-DNA
promoter	I-DNA
exhibits	O
B-cell-specific	O
activity	O
and	O
contains	O
SP1	B-DNA
,	I-DNA
ETS	I-DNA
,	I-DNA
OCT	I-DNA
,	I-DNA
and	I-DNA
IKAROS/LYF-1	I-DNA
transcription	I-DNA
factor	I-DNA
motifs	I-DNA
.	O

All	O
these	O
motifs	O
are	O
strikingly	O
conserved	O
in	O
sequence	O
and	O
placement	O
relative	O
to	O
the	O
previously	O
characterized	O
murine	B-DNA
B29	I-DNA
promoter	I-DNA
.	O

Additional	O
upstream	O
gene	O
segments	O
dramatically	O
affected	O
B29	B-protein
minimal	B-DNA
promoter	I-DNA
activity	O
.	O

A	O
newly	O
identified	O
motif	O
called	O
the	O
B29	B-DNA
conserved	I-DNA
sequence	I-DNA
(	O
BCS	B-DNA
)	O
,	O
found	O
upstream	O
of	O
both	O
human	B-DNA
and	I-DNA
murine	I-DNA
B29	I-DNA
promoters	I-DNA
,	O
appears	O
to	O
stimulate	O
B29	B-protein
transcription	O
through	O
a	O
novel	O
mechanism	O
.	O

A	O
single	O
BCS	B-DNA
had	O
little	O
effect	O
either	O
on	O
the	O
minimal	O
B29	B-DNA
promoter	I-DNA
or	O
on	O
a	O
heterologous	O
promoter	O
.	O

Instead	O
,	O
the	O
BCS	B-DNA
stimulated	O
transcription	O
by	O
counteracting	O
5	B-DNA
'	I-DNA
negative	I-DNA
regulatory	I-DNA
DNA	I-DNA
sequences	I-DNA
that	O
block	O
the	O
activity	O
of	O
the	O
B29	B-protein
minimal	B-DNA
promoter	I-DNA
in	O
its	O
absence	O
.	O

These	O
findings	O
indicate	O
that	O
B29	B-DNA
gene	I-DNA
expression	O
is	O
controlled	O
by	O
the	O
complex	O
interplay	O
of	O
positive	O
and	O
negative	B-DNA
regulatory	I-DNA
elements	I-DNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

The	NULL
Promoter	NULL
and	NULL
5	NULL
'	NULL
Flanking	NULL
Sequences	NULL
Controlling	NULL
Human	NULL
B29	NULL
Gene	NULL
Expression	NULL
By	NULL
Alexis	NULL
A.	NULL
Thompson	NULL
,	NULL
William	NULL
J	NULL
.	NULL

Wood	NULL
Jr	NULL
,	NULL
Michael	NULL
J.	NULL
Gilly	NULL
,	NULL
Michael	NULL
A.	NULL
Damore	NULL
,	NULL
Sidne	NULL
A.	NULL
Omori	NULL
,	NULL
and	NULL
Randolph	NULL
Wail	NULL
The	NULL
product	NULL
of	NULL
the	NULL
B-cell-specific	NULL
829	NULL
gene	NULL
(	NULL
B29	NULL
,	NULL
ig	NULL
$	NULL
B	NULL
,	NULL
CD79b	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
Ig-mediated	NULL
B-cell	NULL
activation	NULL
via	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
(	NULL
BCR	NULL
)	NULL
on	NULL
human	NULL
and	NULL
murine	NULL
B	NULL
lymphocytes	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
pivotal	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
human	NULL
genomic	NULL
DNA	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
829	NULL
ATG	NULL
start	NULL
codon	NULL
for	NULL
transcriptional	NULL
control	NULL
activity	NULL
.	NULL

The	NULL
human	NULL
B29	NULL
gene	NULL
lacks	NULL
either	NULL
a	NULL
TATA	NULL
or	NULL
a	NULL
CAAT	NULL
box	NULL
and	NULL
transcription	NULL
is	NULL
initiated	NULL
at	NULL
multiple	NULL
sites	NULL
.	NULL

The	NULL
minimal	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
is	NULL
contained	NULL
within	NULL
a	NULL
193-bp	NULL
region	NULL
5	NULL
'	NULL
of	NULL
these	NULL
multiple	NULL
start	NULL
sites	NULL
.	NULL

This	NULL
minimal	NULL
promoter	NULL
exhibits	NULL
B-cell-specific	NULL
activity	NULL
and	NULL
contains	NULL
SP1	NULL
,	NULL
ETS	NULL
,	NULL
OCT	NULL
,	NULL
and	NULL
IKAROS/LYF-1	NULL
transcription	NULL
factor	NULL
motifs	NULL
.	NULL

All	NULL
these	NULL
motifs	NULL
are	NULL
strikingly	NULL
conserved	NULL
in	NULL
sequence	NULL
and	NULL
placement	NULL
relative	NULL
to	NULL
the	NULL
previously	NULL
charac-	NULL
HE	NULL
STRUCTURE	NULL
AND	NULL
function	NULL
of	NULL
Igs	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
B-cell	NULL
development	NULL
has	NULL
been	NULL
studied	NULL
exten-sively	NULL
,	NULL
but	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
has	NULL
been	NULL
only	NULL
recently	NULL
elucidated	NULL
.	NULL
``	NULL

All	NULL
Ig	NULL
isotypes	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
B	NULL
lymphocytes	NULL
are	NULL
associated	NULL
with	NULL
heterodimeric	NULL
complexes	NULL
of	NULL
two	NULL
transmembrane	NULL
pro-teins	NULL
,	NULL
designated	NULL
mb-1	NULL
(	NULL
Iga	NULL
,	NULL
CD792	NULL
)	NULL
and	NULL
B29	NULL
(	NULL
Ig	NULL
B	NULL
,	NULL
CD79b	NULL
)	NULL
,	NULL
which	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
mb-/	NULL
and	NULL
B29	NULL
genes	NULL
,	NULL
respec-tively	NULL
.	NULL
``	NULL

Membrane-bound	NULL
Igs	NULL
and	NULL
mb-1-B29	NULL
heterodimers	NULL
comprise	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
(	NULL
BCR	NULL
)	NULL
.	NULL

The	NULL
mb-1	NULL
and	NULL
B29	NULL
proteins	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
intracellular	NULL
as-sembly	NULL
,	NULL
translocation	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
display	NULL
of	NULL
the	NULL
BCR	NULL
complex	NULL
on	NULL
B	NULL
lymphocytes	NULL
.	NULL
``	NULL

Antigen	NULL
binding	NULL
to	NULL
Ig	NULL
in	NULL
the	NULL
BCR	NULL
signals	NULL
B-cell	NULL
activation	NULL
through	NULL
the	NULL
mb-1-B29	NULL
complexes	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
that	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
associated	NULL
CD3	NULL
subunits	NULL
.	NULL
``	NULL

The	NULL
cytoplasmic	NULL
tails	NULL
of	NULL
B29	NULL
and	NULL
mb-1	NULL
contain	NULL
highly	NULL
conserved	NULL
amino	NULL
acid	NULL
elements	NULL
present	NULL
in	NULL
other	NULL
signal	NULL
transducing	NULL
proteins	NULL
in	NULL
membrane	NULL
receptor	NULL
complexes	NULL
(	NULL
eg	NULL
,	NULL
CD3	NULL
&	NULL
,	NULL
7	NULL
,	NULL
y	NULL
,	NULL
6	NULL
chains	NULL
,	NULL
CD22	NULL
,	NULL
and	NULL
Fc	NULL
,	NULL
receptor	NULL
#	NULL
and	NULL
y	NULL
chains	NULL
)	NULL
.	NULL
``	NULL

These	NULL
antigen	NULL
receptor	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Division	NULL
of	NULL
Hematology/On-cology	NULL
,	NULL
Gwynne	NULL
Hazen	NULL
Cherry	NULL
Memorial	NULL
Laboratories	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
The	NULL
Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
UCLA	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
March	NULL
22	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
August	NULL
21	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
Grants	NULL
No	NULL
.	NULL

CA12800	NULL
and	NULL
GM40185	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
;	NULL
to	NULL
R.W	NULL
.	NULL
)	NULL

and	NULL
by	NULL
a	NULL
Minority	NULL
Medical	NULL
Faculty	NULL
Development	NULL
Award	NULL
from	NULL
the	NULL
Robert	NULL
Wood	NULL
Johnson	NULL
Foundation	NULL
(	NULL
AA.T	NULL
.	NULL
)	NULL

.	NULL

W.J.W	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
Institutional	NULL
Training	NULL
Grant	NULL
No	NULL
.	NULL

CAO9120	NULL
.	NULL

M.J.G	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
NIH	NULL
National	NULL
Institutional	NULL
Research	NULL
Service	NULL
Awards	NULL
No	NULL
.	NULL

€CA09056	NULL
and	NULL
CAO9120	NULL
.	NULL

S.A.0O	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
National	NULL
Science	NULL
Foundation	NULL
Fellowship	NULL
RCD	NULL
8954888	NULL
and	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Award	NULL
No	NULL
.	NULL

NRSA	NULL
GMO7104	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Alexis	NULL
A.	NULL
Thompson	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
10833	NULL
LeConte	NULL
Ave	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90095	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8702-0037	NULL
$	NULL
3.00/0	NULL
666	NULL
terized	NULL
murine	NULL
B29	NULL
promoter	NULL
.	NULL

Additional	NULL
upstream	NULL
gene	NULL
segments	NULL
dramatically	NULL
affected	NULL
B29	NULL
minimal	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
newly	NULL
identified	NULL
motif	NULL
called	NULL
the	NULL
B29	NULL
conserved	NULL
sequence	NULL
(	NULL
BCS	NULL
)	NULL
,	NULL
found	NULL
upstream	NULL
of	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
pro-moters	NULL
,	NULL
appears	NULL
to	NULL
stimulate	NULL
B29	NULL
transcription	NULL
through	NULL
a	NULL
novel	NULL
mechanism	NULL
.	NULL

A	NULL
single	NULL
BCS	NULL
had	NULL
little	NULL
effect	NULL
either	NULL
on	NULL
the	NULL
minimal	NULL
B29	NULL
promoter	NULL
or	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

instead	NULL
,	NULL
the	NULL
BCS	NULL
stimulated	NULL
transcription	NULL
by	NULL
counteracting	NULL
5	NULL
'	NULL
negative	NULL
regulatory	NULL
DNA	NULL
sequences	NULL
that	NULL
block	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
B29	NULL
minimal	NULL
promoter	NULL
in	NULL
its	NULL
absence	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
B29	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
complex	NULL
interplay	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

homology	NULL
sequences	NULL
(	NULL
ARH1	NULL
)	NULL
associate	NULL
with	NULL
src	NULL
kinase	NULL
family	NULL
members	NULL
and	NULL
other	NULL
kinases	NULL
to	NULL
activate	NULL
effector	NULL
pathways	NULL
that	NULL
control	NULL
B-lymphocyte	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL
``	NULL

Commitment	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
is	NULL
marked	NULL
in	NULL
part	NULL
by	NULL
B29	NULL
gene	NULL
expression	NULL
in	NULL
pro-B	NULL
cells	NULL
.	NULL
``	NULL

B29	NULL
gene	NULL
expression	NULL
is	NULL
initiated	NULL
before	NULL
heavy	NULL
chain	NULL
rearrangement	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
pro-B	NULL
cells	NULL
.	NULL

'*	NULL
``	NULL
B29	NULL
mRNA	NULL
is	NULL
expressed	NULL
throughout	NULL
all	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
,	NULL
including	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
,	NULL
and	NULL
provides	NULL
a	NULL
definitive	NULL
marker	NULL
for	NULL
human	NULL
B-cell	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
.	NULL

B29	NULL
is	NULL
consistently	NULL
found	NULL
in	NULL
association	NULL
with	NULL
cytoplasmic	NULL
Ig	NULL
L	NULL
heavy	NULL
chain	NULL
in	NULL
human	NULL
pre-B-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
``	NULL
and	NULL
B29	NULL
expression	NULL
in	NULL
the	NULL
lymphocyte	NULL
predominant	NULL
subtype	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
has	NULL
been	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
B-cell	NULL
origin	NULL
of	NULL
these	NULL
neoplastic	NULL
cells	NULL
.	NULL
``	NULL

'	NULL
We	NULL
recently	NULL
reported	NULL
the	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
murine	NULL
829	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
murine	NULL
£29	NULL
minimal	NULL
promoter	NULL
exhibiting	NULL
high	NULL
activity	NULL
and	NULL
B-cell	NULL
specificity	NULL
is	NULL
167-bp	NULL
long	NULL
.	NULL

It	NULL
lacks	NULL
a	NULL
TATA	NULL
box	NULL
or	NULL
other	NULL
unique	NULL
transcription	NULL
initiator	NULL
element	NULL
and	NULL
exhibits	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
.	NULL

The	NULL
murine	NULL
promoter	NULL
contains	NULL
a	NULL
critical	NULL
octamer	NULL
motif	NULL
(	NULL
OCT	NULL
)	NULL
,	NULL
identical	NULL
to	NULL
the	NULL
motifs	NULL
in	NULL
Ig	NULL
light	NULL
and	NULL
heavy	NULL
chain	NULL
promoters	NULL
and	NULL
in	NULL
the	NULL
heavy	NULL
chain	NULL
intron	NULL
enhancer	NULL
,	NULL
which	NULL
controls	NULL
its	NULL
tissue-specific	NULL
activity	NULL
.	NULL

DNA	NULL
motifs	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
ETS	NULL
,	NULL
SP1	NULL
,	NULL
and	NULL
IKAROS/LYF-1	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
maximum	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
promoter	NULL
.	NULL
``	NULL

We	NULL
previously	NULL
isolated	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
and	NULL
found	NULL
a	NULL
remarkable	NULL
degree	NULL
of	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
murine	NULL
gene	NULL
,	NULL
particularly	NULL
in	NULL
the	NULL
transmembrane	NULL
and	NULL
cytoplasmic	NULL
segments	NULL
.	NULL
``	NULL

The	NULL
exon/intron	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
gene	NULL
.	NULL

'**	NULL
The	NULL
human	NULL
B29	NULL
gene	NULL
is	NULL
a	NULL
single	NULL
copy	NULL
gene	NULL
located	NULL
at	NULL
human	NULL
chromosome	NULL
locus	NULL
,	NULL
17423	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
and	NULL
analyzed	NULL
it	NULL
for	NULL
transcriptional	NULL
control	NULL
activity	NULL
.	NULL

Through	NULL
a	NULL
series	NULL
of	NULL
deletions	NULL
and	NULL
functional	NULL
expression	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
delineated	NULL
the	NULL
minimal	NULL
human	NULL
B-cell-specific	NULL
promoter	NULL
.	NULL

This	NULL
promoter	NULL
is	NULL
virtually	NULL
identical	NULL
to	NULL
its	NULL
murine	NULL
counterpart	NULL
and	NULL
contains	NULL
the	NULL
same	NULL
array	NULL
of	NULL
DNA	NULL
motifs	NULL
shown	NULL
to	NULL
be	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
murine	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
2	NULL
(	NULL
January	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
666-673	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HUMAN	NULL
829	NULL
PROMOTER	NULL
AND	NULL
5	NULL
'	NULL
FLANKING	NULL
SEQUENCES	NULL
B29	NULL
promoter	NULL
.	NULL

We	NULL
find	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
B29	NULL
minimal	NULL
promoter	NULL
is	NULL
controlled	NULL
by	NULL
upstream	NULL
negative	NULL
and	NULL
positive	NULL
regulatory	NULL
sequences	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
new	NULL
transcription	NULL
control	NULL
motif	NULL
in	NULL
this	NULL
upstream	NULL
region	NULL
called	NULL
the	NULL
B29	NULL
conserved	NULL
sequence	NULL
(	NULL
BCS	NULL
)	NULL
that	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
genes	NULL
.	NULL

The	NULL
BCS	NULL
apparently	NULL
functions	NULL
as	NULL
a	NULL
positive	NULL
transcription	NULL
control	NULL
element	NULL
by	NULL
counteracting	NULL
the	NULL
inhibitory	NULL
activity	NULL
of	NULL
nearby	NULL
DNA	NULL
sequences	NULL
on	NULL
the	NULL
minimal	NULL
B29	NULL
promoter	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Genomic	NULL
clone	NULL
isolation	NULL
.	NULL

_	NULL
A	NULL
6-kb	NULL
EcoRI	NULL
human	NULL
genomic	NULL
DNA	NULL
fragment	NULL
hybridizing	NULL
with	NULL
B29	NULL
5°	NULL
cDNA	NULL
restriction	NULL
fragments	NULL
and	NULL
synthetic	NULL
oligonucleotides	NULL
was	NULL
cloned	NULL
in	NULL
both	NULL
orientations	NULL
.	NULL
``	NULL

This	NULL
plasmid	NULL
(	NULL
pBS27-I	NULL
)	NULL
was	NULL
further	NULL
digested	NULL
with	NULL
Kpn	NULL
I	NULL
creating	NULL
a	NULL
2.7-kb	NULL
EcoRl-Kpn	NULL
I	NULL
subclone	NULL
(	NULL
pBS27-IB/Kpn	NULL
I	NULL
)	NULL
containing	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
B29	NULL
coding	NULL
region	NULL
.	NULL

Sequencing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
dideoxy	NULL
method	NULL
of	NULL
Sanger	NULL
using	NULL
Sequenase	NULL
(	NULL
US	NULL
Biochemical	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
GenBank	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

U22954	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
and	NULL
culture	NULL
conditions	NULL
.	NULL

-	NULL
The	NULL
human	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
(	NULL
729	NULL
B-lymphoblastoid	NULL
,	NULL
Namalwa	NULL
B-cell	NULL
,	NULL
697	NULL
pre-B-cell	NULL
,	NULL
H929	NULL
and	NULL
RPMI8226	NULL
myeloma	NULL
cells	NULL
,	NULL
Jurkat	NULL
T-cell	NULL
leukemia	NULL
,	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
gluta-mine.and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Nalm-6	NULL
,	NULL
a	NULL
human	NULL
pre-B	NULL
leukemia	NULL
,	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
and	NULL
10	NULL
%	NULL
defined-iron	NULL
supplemented	NULL
newborn	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
)	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
were	NULL
maintained	NULL
at	NULL
a	NULL
maximum	NULL
cell	NULL
density	NULL
of	NULL
2	NULL
x	NULL
10¢/mL	NULL
.	NULL

RNAse	NULL
protection	NULL
assays	NULL
.	NULL

-	NULL
A	NULL
700-bp	NULL
Apa	NULL
I	NULL
fragment	NULL
of	NULL
pBS27-1B/Kpn	NULL
I	NULL
containing	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
B29	NULL
gene	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pGEMSZf	NULL
(	NULL
-	NULL
)	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

Using	NULL
1	NULL
ug	NULL
of	NULL
Age	NULL
I-linearized	NULL
plasmid	NULL
,	NULL
a	NULL
``	NULL
P-CTP	NULL
(	NULL
650	NULL
Ci/mmol	NULL
;	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
(	NULL
20	NULL
U	NULL
;	NULL
Promega	NULL
)	NULL
,	NULL
a	NULL
450-bp	NULL
RNA	NULL
probe	NULL
with	NULL
high	NULL
specific	NULL
activity	NULL
was	NULL
synthesized	NULL
.	NULL

After	NULL
DNAse	NULL
treatment	NULL
to	NULL
remove	NULL
the	NULL
template	NULL
,	NULL
the	NULL
probe	NULL
was	NULL
purified	NULL
over	NULL
a	NULL
G-50	NULL
Sephadex	NULL
spin	NULL
column	NULL
and	NULL
8	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
ethanol	NULL
precipitated	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
and	NULL
then	NULL
hybridized	NULL
at	NULL
48°C	NULL
overnight	NULL
.	NULL

Unannealed	NULL
probe	NULL
was	NULL
digested	NULL
with	NULL
a	NULL
1:100	NULL
dilution	NULL
of	NULL
RNAse	NULL
A/TI	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
and	NULL
the	NULL
protected	NULL
fragments	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Gels	NULL
were	NULL
fixed	NULL
and	NULL
dried	NULL
before	NULL
autoradiography	NULL
.	NULL

Reporter	NULL
gene	NULL
assays	NULL
.	NULL

-	NULL
Transient	NULL
gene	NULL
expression	NULL
was	NULL
performed	NULL
by	NULL
electroporation	NULL
using	NULL
vectors	NULL
containing	NULL
the	NULL
bacterial	NULL
gene	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
,	NULL
as	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

An	NULL
800-bp	NULL
Pst	NULL
I	NULL
fragment	NULL
from	NULL
pBS27-IB/Kpn	NULL
I	NULL
encompassing	NULL
the	NULL
B29	NULL
transcription	NULL
start	NULL
site	NULL
cluster	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
promoterless	NULL
pCAT	NULL
Basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
the	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
orientation	NULL
.	NULL

The	NULL
same	NULL
fragment	NULL
was	NULL
cloned	NULL
in	NULL
reverse	NULL
orientation	NULL
into	NULL
a	NULL
pCAT	NULL
Basic	NULL
vector	NULL
that	NULL
has	NULL
been	NULL
modified	NULL
to	NULL
incorporate	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
pGEMSZf	NULL
(	NULL
-	NULL
}	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

A	NULL
series	NULL
of	NULL
5	NULL
``	NULL
deletion	NULL
mutants	NULL
of	NULL
both	NULL
clones	NULL
were	NULL
prepared	NULL
by	NULL
exonuclease	NULL
III/	NULL
mung	NULL
bean	NULL
nuclease	NULL
treatment	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Sequencing	NULL
was	NULL
performed	NULL
to	NULL
delineate	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
.	NULL

A	NULL
double-stranded	NULL
synthetic	NULL
oligomer	NULL
,	NULL
5°	NULL
CCAAGAGGCTCT-GCTCTGGGCCCCTCCAGA	NULL
3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
BCS	NULL
at	NULL
-507	NULL
to	NULL
-477	NULL
was	NULL
inserted	NULL
by	NULL
blunt	NULL
ligation	NULL
in	NULL
both	NULL
orientations	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
selected	NULL
deletion	NULL
constructs	NULL
.	NULL

This	NULL
same	NULL
oligomer	NULL
was	NULL
also	NULL
cloned	NULL
into	NULL
a	NULL
HindIII	NULL
site	NULL
in	NULL
the	NULL
J21	NULL
vector	NULL
that	NULL
contains	NULL
the	NULL
minimal	NULL
c-fos	NULL
promoter	NULL
5	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL
``	NULL

A	NULL
133-bp	NULL
genomic	NULL
fragment	NULL
that	NULL
667	NULL
included	NULL
the	NULL
BCS	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
end	NULL
of	NULL
a	NULL
reverse	NULL
deletion	NULL
mutant	NULL
and	NULL
also	NULL
subcloned	NULL
into	NULL
J21	NULL
.	NULL

Plasmids	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
cell	NULL
lines	NULL
in	NULL
culture	NULL
by	NULL
electroporation	NULL
(	NULL
BRL	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Samples	NULL
of	NULL
approximately	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
and	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
test	NULL
plasmid	NULL
then	NULL
electroporated	NULL
at	NULL
1,180	NULL
uF	NULL
and	NULL
625	NULL
V/cm	NULL
.	NULL

After	NULL
being	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
minutes	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
transferred	NULL
to	NULL
10	NULL
mL	NULL
of	NULL
warm	NULL
media	NULL
and	NULL
placed	NULL
in	NULL
a	NULL
37°C	NULL
incubator	NULL
.	NULL

After	NULL
2	NULL
days	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
in	NULL
200	NULL
mmol/L	NULL
K	NULL
;	NULL
PO	NULL
,	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
2	NULL
mmol/L	NULL
dithiothrei-tol	NULL
,	NULL
30	NULL
mmol/L	NULL
MgSQO	NULL
,	NULL
,	NULL
and	NULL
10	NULL
mmol/L	NULL
ATP	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
CAT	NULL
reporter	NULL
gene	NULL
activity	NULL
by	NULL
acetylation	NULL
of	NULL
``	NULL
C-labeled	NULL
chloramphenicol	NULL
and	NULL
thin-layer	NULL
chromatography	NULL
separation	NULL
.	NULL

All	NULL
studies	NULL
were	NULL
normalized	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
cotransfected	NULL
pRSV-luciferase	NULL
plasmid	NULL
to	NULL
correct	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

Measurements	NULL
of	NULL
luciferase	NULL
enzyme	NULL
activity	NULL
from	NULL
30	NULL
pL	NULL
of	NULL
each	NULL
cell	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
gL	NULL
of	NULL
1	NULL
mmol/L	NULL
luciferin	NULL
were	NULL
performed	NULL
on	NULL
an	NULL
automated	NULL
injection	NULL
luminometer	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
697	NULL
,	NULL
729	NULL
,	NULL
8226	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HL-60	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
using	NULL
the	NULL
method	NULL
previously	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
,	NULL
``	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Tris-HCl	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
was	NULL
used	NULL
in	NULL
place	NULL
of	NULL
HEPES	NULL
in	NULL
the	NULL
extraction	NULL
buffers	NULL
and	NULL
dialysate	NULL
,	NULL
and	NULL
the	NULL
optimized	NULL
concentration	NULL
of	NULL
salt	NULL
in	NULL
the	NULL
final	NULL
extraction	NULL
buffer	NULL
was	NULL
0.4	NULL
mol/L	NULL
KCI	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
extract	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Phar-macia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
and	NULL
10,000	NULL
cpm	NULL
of	NULL
gel	NULL
purified	NULL
yP	NULL
``	NULL
end-labeled	NULL
oligonucleotide	NULL
or	NULL
DNA	NULL
fragment	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
50-	NULL
,	NULL
125-	NULL
,	NULL
and	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
.	NULL

A	NULL
double-stranded	NULL
unrelated	NULL
oligonucleotide	NULL
with	NULL
the	NULL
following	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
the	NULL
nonspecific	NULL
competitor	NULL
:	NULL
5'TGCGAT-TTGCATATTA3	NULL
'	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
5	NULL
%	NULL
nonde-naturing	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
acrylamide	NULL
:	NULL
bisacrylamide	NULL
80:1	NULL
)	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
buffer	NULL
.	NULL

RESULTS	NULL
5	NULL
'	NULL
Sequence	NULL
and	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
.	NULL

A	NULL
2.7-kb	NULL
human	NULL
genomic	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
B29	NULL
gene	NULL
was	NULL
cloned	NULL
using	NULL
probes	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
human	NULL
£29	NULL
cDNA	NULL
sequence	NULL
.	NULL
``	NULL

The	NULL
DNA	NULL
sequence	NULL
extending	NULL
1.3	NULL
kb	NULL
upstream	NULL
from	NULL
the	NULL
human	NULL
B29	NULL
translation	NULL
initiation	NULL
codon	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
coding	NULL
for	NULL
the	NULL
human	NULL
B29	NULL
leader	NULL
sequence	NULL
is	NULL
76	NULL
%	NULL
identical	NULL
to	NULL
murine	NULL
B29	NULL
leader	NULL
sequence	NULL
and	NULL
exon	NULL
1	NULL
ends	NULL
at	NULL
the	NULL
same	NULL
5	NULL
``	NULL
splice	NULL
junction	NULL
as	NULL
the	NULL
murine	NULL
B29	NULL
gene	NULL
.	NULL
``	NULL

As	NULL
is	NULL
the	NULL
case	NULL
for	NULL
the	NULL
murine	NULL
B29	NULL
gene	NULL
,	NULL
the	NULL
human	NULL
B29	NULL
5	NULL
sequence	NULL
does	NULL
not	NULL
contain	NULL
any	NULL
sequence	NULL
resembling	NULL
a	NULL
TATA	NULL
or	NULL
a	NULL
CAAT	NULL
box	NULL
for	NULL
several	NULL
hundred	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
exon	NULL
1	NULL
.	NULL

The	NULL
B29	NULL
gene	NULL
,	NULL
like	NULL
many	NULL
genes	NULL
lacking	NULL
a	NULL
TATA	NULL
box	NULL
,	NULL
has	NULL
multiple	NULL
transcription	NULL
start	NULL
sites	NULL
.	NULL

RNAse	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
RNA	NULL
samples	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
to	NULL
identify	NULL
the	NULL
termini	NULL
of	NULL
B29	NULL
gene	NULL
transcripts	NULL
.	NULL

The	NULL
synthetic	NULL
RNA	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
spanned	NULL
exon	NULL
1	NULL
and	NULL
extended	NULL
325	NULL
nucleotides	NULL
5	NULL
of	NULL
the	NULL
ATG	NULL
translation	NULL
start	NULL
codon	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
assays	NULL
using	NULL
RNA	NULL
samples	NULL
from	NULL
B-lineage	NULL
cell	NULL
lines	NULL
and	NULL
a	NULL
T-cell	NULL
line	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

Five	NULL
protected	NULL
RNA	NULL
probe	NULL
fragments	NULL
were	NULL
seen	NULL
with	NULL
RNA	NULL
from	NULL
two	NULL
B-cell	NULL
lines	NULL
(	NULL
Ramos	NULL
and	NULL
Namalwa	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
a	NULL
pre-B-cell	NULL
line	NULL
(	NULL
Nalm	NULL
6	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
a	NULL
myeloma	NULL
cell	NULL
line	NULL
(	NULL
H929	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
any	NULL
protected	NULL
fragments	NULL
with	NULL
RNA	NULL
from	NULL
the	NULL
T-cell	NULL
line	NULL
(	NULL
Jurkat	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
B-cell	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

668	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
-1037	NULL
GACGTCCAGG	NULL
TCCCCCAGAA	NULL
CCCGTCCCTT	NULL
GTCTTCGACC	NULL
ACACCCCCTCT	NULL
GGGAGTCCAG	NULL
-	NULL
60	NULL
-977	NULL
GAGGTCGACA	NULL
TAGGACGGAC	NULL
AGGAGTCTCA	NULL
CGACCTACCT	NULL
CGGTGTCACG	NULL
AGTCCTTGAC	NULL
120	NULL
-917	NULL
-	NULL
TATATTTGAG	NULL
TGGAAACGCG	NULL
GGGACGGGGA	NULL
CCCAGGTTAC	NULL
GTCGGGGAAG	NULL
TCTCTACGGG	NULL
180	NULL
-857	NULL
AACACGTCCC	NULL
_	NULL
GTGTTGTACG	NULL
TGTTCACATG	NULL
TGTCGTACGA	NULL
ACGTCTGGAG	NULL
TCAGAGCTGC	NULL
240	NULL
¥	NULL
-797	NULL
-	NULL
AGACAACAAT	NULL
-	NULL
TCAACGCACT	NULL
CAGAGTCCCA	NULL
CAGTTAAGAA	NULL
CTCCCTGAAG	NULL
AAGCCCCCAG	NULL
300	NULL
-737	NULL
TGGCTGCGTG	NULL
GTGGATTTTC	NULL
GCAAAGCTGT	NULL
CTCCACCTAC	NULL
ATCCACCCTG	NULL
TTTGGCAGCC	NULL
360	NULL
¥	NULL
-677	NULL
CCTACATACT	NULL
CTTTCACAGC	NULL
ATGAGGAAGG	NULL
GAGGCCTCTC	NULL
ACCAAGACCT	NULL
GGACTGAATC	NULL
420	NULL
-617	NULL
-	NULL
TTCTCCCAGT	NULL
GGCTGCCACA	NULL
-	NULL
CCTGACCTGC	NULL
TCTTGCTCCA	NULL
GAACCTCTGT	NULL
GGCTCCCATA	NULL
_	NULL
480	NULL
¥	NULL
B29	NULL
CONSERVED	NULL
SEQUENCE	NULL
-557	NULL
CTCCACAGGG	NULL
TCAACTTCCA	NULL
ACATGGCTGC	NULL
CTGCACTCCA	NULL
G	NULL
CCAAGAGGE	NULL
TICTGCTCTGG	NULL
540	NULL
(	NULL
BCS	NULL
)	NULL
M	NULL
-497	NULL
GCCCCICCAG	NULL
ATGCCTGACC	NULL
TGGGTCTGTG	NULL
GCTGCCCTGT	NULL
CCTTCTTCAG	NULL
TGCTCCTCTT	NULL
-	NULL
600	NULL
-437	NULL
CCCGCTGGGT	NULL
GAGGAATAGT	NULL
TCAGGACAGA	NULL
GGAGCTAAGT	NULL
TCAGGTTCAT	NULL
TCATAGGACA	NULL
_	NULL
660	NULL
-377	NULL
GGTGCCTATT	NULL
TCGCTCACGG	NULL
CCCAGGAATA	NULL
GAGACTTGCC	NULL
GGGCTCGGCC	NULL
CTTCGGGGAG	NULL
720	NULL
v	NULL
-317	NULL
CTGGCAGACG	NULL
GCAGAGGGGA	NULL
GGCTGGCTGG	NULL
CCCAGGGGAT	NULL
GACCACCGGT	NULL
GGGGTAAGCA	NULL
780	NULL
Fig	NULL
1	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
-257	NULL
CAGACAGAGG	NULL
GGAGCACAGG	NULL
CTTCCCCCAG	NULL
AAGACTGAGA	NULL
GGCCCCCCAG	NULL
AGGCATCCAC	NULL
_	NULL
840	NULL
_	NULL
of	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
v	NULL
human	NULL
B29	NULL
gene	NULL
.	NULL

A	NULL
1.2-kb	NULL
geno	NULL
--	NULL
197	NULL
AGAGGACCCC	NULL
AGCTGTGCTG	NULL
CCCAAGCTGG	NULL
GCGACCGCCA	NULL
AACCTTAGCG	NULL
GCCCAGCTGA	NULL
-	NULL
900	NULL
W'Cfragment°°	NULL
``	NULL
ta	NULL
'	NULL
``	NULL
'	NULL
``	NULL
9thef	NULL
``	NULL
5t	NULL
IKAROS/LyF-1	NULL
oct	NULL
intron	NULL
a.nd	NULL
exon	NULL
and	NULL
the	NULL
B29	NULL
[	NULL
no	NULL
--	NULL
137	NULL
CAAAAGCCTG	NULL
CCCTCCCCCA	NULL
GGGTCCCCGG	NULL
AGAGCTGGTG	NULL
CCTCCCCTGG	NULL
GTCCCA	NULL
ATT	NULL
96q	NULL
_	NULL
moter	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
multiple	NULL
ETs	NULL
ETS	NULL
Sp1	NULL
tranzczpt	NULL
}	NULL
?	NULL

start	NULL
sges	NULL
f	NULL
(	NULL
”	NULL
hare	NULL
marked	NULL
.	NULL

e	NULL
most	NULL
5°	NULL
of	NULL
these	NULL
-77	NULL
QQAIGG£A§§__AAGGGGEETG	NULL
GIQfEQfAGA	NULL
GGCGGGGAGG	NULL
GGACAGGCTG	NULL
CAGCCGGTGC	NULL
1020	NULL
sites	NULL
is	NULL
designated	NULL
+1	NULL
.	NULL

Consensus	NULL
binding	NULL
sites	NULL
for	NULL
octamer	NULL
,	NULL
-17	NULL
_	NULL
AGTTACACGT	NULL
TTTCCTCCAA	NULL
GGAGCCTCGG	NULL
ACGTTGTCAC	NULL
GGGTTTGGGG	NULL
TCGGGGACAG	NULL
1080	NULL
ETS	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
IKAROS/LyF-1	NULL
within	NULL
the	NULL
B29	NULL
promoter	NULL
region	NULL
are	NULL
labeled	NULL
.	NULL

Arrows	NULL
(	NULL
¥	NULL
)	NULL
indicate	NULL
1140	NULL
the	NULL
5°	NULL
ends	NULL
of	NULL
deletion	NULL
constructs	NULL
used	NULL
in	NULL
reporter	NULL
gene	NULL
.	NULL

Nucleotide	NULL
se	NULL
f	NULL
CAGAACCCAC	NULL
-	NULL
GACGAGGCCT	NULL
-	NULL
GTGGGGTTTG	NULL
CTCTCATCTC	NULL
_	NULL
1200	NULL
.	NULL

ing	NULL
frat	NULL
codma	NULL
exon	NULL
is	NULL
in	NULL
the	NULL
+164	NULL
-	NULL
CAGCTGTCTG	NULL
GG	NULL
specificity	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

RPMI	NULL
8226	NULL
,	NULL
a	NULL
myeloma	NULL
cell	NULL
line	NULL
that	NULL
secretes	NULL
A	NULL
light	NULL
chains	NULL
(	NULL
but	NULL
not	NULL
heavy	NULL
chains	NULL
)	NULL
,	NULL
had	NULL
no	NULL
detectable	NULL
B29	NULL
mRNA	NULL
in	NULL
Northern	NULL
blots	NULL
,	NULL
and	NULL
did	NULL
not	NULL
show	NULL
any	NULL
protected	NULL
fragments	NULL
in	NULL
the	NULL
RNAse	NULL
protection	NULL
assay	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
is	NULL
initiated	NULL
from	NULL
a	NULL
cluster	NULL
of	NULL
5	NULL
start	NULL
sites	NULL
located	NULL
44	NULL
to	NULL
54	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
codon	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
also	NULL
confirm	NULL
that	NULL
human	NULL
B29	NULL
gene	NULL
transcripts	NULL
are	NULL
expressed	NULL
throughout	NULL
B-cell	NULL
development	NULL
and	NULL
that	NULL
the	NULL
same	NULL
dominant	NULL
transcription	NULL
start	NULL
sites	NULL
are	NULL
used	NULL
at	NULL
all	NULL
stages	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
*	NULL
5	NULL
'	NULL
Sequences	NULL
controlling	NULL
human	NULL
B29	NULL
gene	NULL
transcription	NULL
.	NULL

DNA	NULL
fragments	NULL
produced	NULL
by	NULL
successive	NULL
5	NULL
'	NULL
deletions	NULL
of	NULL
the	NULL
sequenced	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
promoterless	NULL
pCATBasic	NULL
reporter	NULL
vector	NULL
and	NULL
analyzed	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
to	NULL
identify	NULL
regions	NULL
with	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
ends	NULL
of	NULL
the	NULL
DNA	NULL
fragments	NULL
resulting	NULL
from	NULL
these	NULL
5	NULL
'	NULL
deletions	NULL
are	NULL
noted	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
the	NULL
mean	NULL
stimulation	NULL
of	NULL
reporter	NULL
CAT	NULL
gene	NULL
expression	NULL
by	NULL
different	NULL
deletion	NULL
constructs	NULL
relative	NULL
to	NULL
the	NULL
first	NULL
coding	NULL
exon	NULL
is	NULL
in	NULL
the	NULL
shaded	NULL
area	NULL
with	NULL
the	NULL
corresponding	NULL
amino	NULL
acid	NULL
sequence	NULL
directly	NULL
above	NULL
.	NULL

the	NULL
promoterless	NULL
pCATBasic	NULL
vector	NULL
.	NULL

The	NULL
-796-bp	NULL
B29	NULL
5	NULL
'	NULL
DNA	NULL
fragment	NULL
produced	NULL
a	NULL
17-fold	NULL
induction	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
human	NULL
B-cell	NULL
line	NULL
,	NULL
729	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
this	NULL
plasmid	NULL
was	NULL
transfected	NULL
into	NULL
another	NULL
human	NULL
B-cell	NULL
line	NULL
,	NULL
Namalwa	NULL
;	NULL
into	NULL
the	NULL
human	NULL
pre-B-cell	NULL
lines	NULL
,	NULL
Nalm-6	NULL
and	NULL
697	NULL
;	NULL
and	NULL
into	NULL
the	NULL
murine	NULL
B-cell	NULL
line	NULL
,	NULL
M12	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
pCAT/-796	NULL
construct	NULL
exhibited	NULL
B-cell-specific	NULL
activity	NULL
as	NULL
it	NULL
failed	NULL
to	NULL
stimulate	NULL
CAT	NULL
activity	NULL
in	NULL
either	NULL
HeLa	NULL
cells	NULL
or	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Further	NULL
5	NULL
'	NULL
deletions	NULL
,	NULL
producing	NULL
DNA	NULL
fragments	NULL
ending	NULL
at	NULL
-643	NULL
,	NULL
-532	NULL
,	NULL
and	NULL
-464	NULL
bp	NULL
,	NULL
successively	NULL
decreased	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
-464	NULL
deletion	NULL
fragment	NULL
was	NULL
reduced	NULL
90	NULL
%	NULL
from	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
-796	NULL
fragment	NULL
(	NULL
ie	NULL
,	NULL
-464	NULL
exhibited	NULL
only	NULL
2-fold	NULL
stimulation	NULL
over	NULL
the	NULL
background	NULL
expression	NULL
with	NULL
the	NULL
promoterless	NULL
pCATBasic	NULL
vector	NULL
;	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Transcription-stimulating	NULL
activity	NULL
then	NULL
increased	NULL
with	NULL
further	NULL
5	NULL
'	NULL
deletion	NULL
to	NULL
-304	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
with	NULL
DNA	NULL
fragment	NULL
-193	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
stimulatory	NULL
activity	NULL
of	NULL
the	NULL
-193	NULL
construct	NULL
(	NULL
ie	NULL
,	NULL
16-fold	NULL
)	NULL
is	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
the	NULL
-796	NULL
construct	NULL
.	NULL

The	NULL
193-bp	NULL
fragment	NULL
is	NULL
the	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HUMAN	NULL
B29	NULL
PROMOTER	NULL
AND	NULL
5°	NULL
FLANKING	NULL
SEQUENCES	NULL
``	NULL
$	NULL
f	NULL
A	NULL
G	NULL
C	NULL
T	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
2	NULL
.	NULL

Ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

A	NULL
genomic	NULL
fragment	NULL
extending	NULL
5	NULL
'	NULL
from	NULL
the	NULL
first	NULL
intron	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
a	NULL
450-bp	NULL
*	NULL
P-labeled	NULL
riboprobe	NULL
that	NULL
was	NULL
hybridized	NULL
to	NULL
20	NULL
ug	NULL
of	NULL
Ramos	NULL
B-cell	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
Namalwa	NULL
B-cell	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
Nalm	NULL
6	NULL
pre-B-cell	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
H929	NULL
plasma	NULL
cell	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
T-cell	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
total	NULL
cellular	NULL
RNA	NULL
and	NULL
treated	NULL
with	NULL
RNAse	NULL
A	NULL
and	NULL
T1	NULL
.	NULL

Multiple	NULL
protected	NULL
fragments	NULL
visible	NULL
by	NULL
autora-diography	NULL
of	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis-urea	NULL
gel	NULL
are	NULL
consistent	NULL
with	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
noted	NULL
in	NULL
most	NULL
TATA-less	NULL
genes	NULL
.	NULL

The	NULL
sequencing	NULL
ladder	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
genomic	NULL
template	NULL
allowed	NULL
for	NULL
precise	NULL
localization	NULL
of	NULL
each	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

shortest	NULL
active	NULL
deletion	NULL
construct	NULL
and	NULL
accordingly	NULL
is	NULL
designated	NULL
the	NULL
minimal	NULL
B-cell-specific	NULL
promoter	NULL
.	NULL

These	NULL
changes	NULL
in	NULL
transcriptional	NULL
activity	NULL
were	NULL
reproducibly	NULL
seen	NULL
in	NULL
four	NULL
independent	NULL
transfections	NULL
with	NULL
the	NULL
set	NULL
of	NULL
5°	NULL
DNA	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
-796	NULL
B29	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
193-bp	NULL
human	NULL
B29	NULL
promoter	NULL
strongly	NULL
stimulated	NULL
transcription	NULL
in	NULL
all	NULL
B-lineage	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
exhibited	NULL
little	NULL
activity	NULL
over	NULL
background	NULL
in	NULL
either	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
murine	NULL
#	NULL
29	NULL
minimal	NULL
promoter	NULL
,	NULL
the	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
is	NULL
B-cell-specific	NULL
.	NULL

This	NULL
minimal	NULL
promoter	NULL
segment	NULL
contains	NULL
the	NULL
same	NULL
array	NULL
of	NULL
transcription	NULL
factor	NULL
motifs	NULL
previously	NULL
shown	NULL
to	NULL
regulate	NULL
the	NULL
activity	NULL
and	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
murine	NULL
829	NULL
minimal	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
ATTTGCAT	NULL
sequence	NULL
exactly	NULL
corresponds	NULL
to	NULL
the	NULL
canonical	NULL
octamer	NULL
motif	NULL
(	NULL
OCT	NULL
)	NULL
.	NULL
``	NULL

Two	NULL
ETS	NULL
motifs	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
OCT	NULL
motif	NULL
are	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
B-cell	NULL
and	NULL
macrophage	NULL
transcription	NULL
factor	NULL
,	NULL
PU.1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ETS	NULL
oncogene	NULL
family	NULL
.	NULL
``	NULL

''	NULL
A	NULL
motif	NULL
for	NULL
IKAROS/LYF-1	NULL
family	NULL
members	NULL
is	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
OCT	NULL
motif	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
All	NULL
these	NULL
motifs	NULL
are	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
minimal	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
containing	NULL
these	NULL
transcription	NULL
factor	NULL
motifs	NULL
is	NULL
91	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
comparable	NULL
sequence	NULL
in	NULL
the	NULL
murine	NULL
B29	NULL
minimal	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
BCS	NULL
.	NULL

_	NULL
We	NULL
next	NULL
analyzed	NULL
the	NULL
active	NULL
regions	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
for	NULL
other	NULL
highly	NULL
conserved	NULL
sequences	NULL
.	NULL

One	NULL
29	NULL
nucleotide	NULL
stretch	NULL
was	NULL
noted	NULL
with	NULL
83	NULL
%	NULL
sequence	NULL
identity	NULL
to	NULL
a	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
gene	NULL
.	NULL

This	NULL
sequence	NULL
(	NULL
5	NULL
)	NULL
CCAAGAGGC-TCTGCTCTGGGCCCCTCCAG	NULL
3	NULL
'	NULL
)	NULL
,	NULL
called	NULL
the	NULL
BCS	NULL
,	NULL
is	NULL
centrally	NULL
located	NULL
in	NULL
the	NULL
-532	NULL
to	NULL
-464	NULL
fragment	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
669	NULL
25	NULL
c	NULL
1	NULL
9	NULL
20	NULL
o	NULL
E	NULL
``	NULL
3	NULL
a	NULL
O	NULL
§	NULL
€	NULL
_	NULL
]	NULL
o	NULL
157	NULL
§	NULL
LL	NULL
a	NULL
s	NULL
197	NULL
O	NULL
J	NULL
<	NULL
J	NULL
<	NULL
<	NULL
5-O	NULL
0	NULL
pCAT	NULL
-796	NULL
-643	NULL
-532	NULL
-464	NULL
-304	NULL
-193	NULL
Fig	NULL
3	NULL
.	NULL

CAT	NULL
reporter	NULL
gene	NULL
assays	NULL
of	NULL
the	NULL
B29	NULL
5°	NULL
flanking	NULL
region	NULL
.	NULL

Deletion	NULL
constructs	NULL
as	NULL
noted	NULL
in	NULL
Fig	NULL
1	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
promoterless	NULL
pCAT	NULL
basic	NULL
vector	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
average	NULL
CAT	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
was	NULL
determined	NULL
by	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
the	NULL
vector	NULL
alone	NULL
(	NULL
CAT	NULL
)	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
normalized	NULL
for	NULL
transfection	NULL
effeciency	NULL
by	NULL
luciferase	NULL
assay	NULL
.	NULL

fragment	NULL
produced	NULL
a	NULL
significant	NULL
(	NULL
5-fold	NULL
)	NULL
decrease	NULL
in	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
upstream	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
homologous	NULL
sequence	NULL
in	NULL
the	NULL
murine	NULL
B29	NULL
gene	NULL
also	NULL
caused	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
transcriptional	NULL
activity	NULL
``	NULL
``	NULL
(	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
BCS	NULL
had	NULL
inherent	NULL
transcriptional	NULL
activity	NULL
,	NULL
a	NULL
double-stranded	NULL
synthetic	NULL
29-bp	NULL
oligomer	NULL
of	NULL
the	NULL
BCS	NULL
was	NULL
inserted	NULL
in	NULL
both	NULL
orientations	NULL
upstream	NULL
of	NULL
the	NULL
the	NULL
c-fos	NULL
promoter	NULL
in	NULL
the	NULL
J21-CAT	NULL
reporter	NULL
gene	NULL
vector	NULL
.	NULL

This	NULL
basal	NULL
promoter	NULL
is	NULL
56-bp	NULL
long	NULL
,	NULL
with	NULL
a	NULL
TATA	NULL
box	NULL
.	NULL
``	NULL

''	NULL
Either	NULL
orientation	NULL
of	NULL
the	NULL
BCS	NULL
produced	NULL
less	NULL
than	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
c-fos	NULL
promoter	NULL
CAT	NULL
activity	NULL
in	NULL
transiently	NULL
transfected	NULL
729	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
BCS	NULL
only	NULL
minimally	NULL
affects	NULL
the	NULL
efficiency	NULL
of	NULL
transcription	NULL
from	NULL
a	NULL
heterologous	NULL
basal	NULL
promoter	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
BCS	NULL
29-bp	NULL
oligomer	NULL
was	NULL
inserted	NULL
in	NULL
both	NULL
orientations	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
B29	NULL
promoter	NULL
and	NULL
the	NULL
-464	NULL
deletion	NULL
construct	NULL
.	NULL

A	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
BCS	NULL
oligomer	NULL
in	NULL
either	NULL
orientation	NULL
upstream	NULL
of	NULL
the	NULL
193-bp	NULL
minimal	NULL
B29	NULL
Table	NULL
1	NULL
.	NULL

Transcriptional	NULL
Activity	NULL
of	NULL
B29	NULL
Promoter	NULL
and	NULL
5	NULL
'	NULL
Region	NULL
in	NULL
Different	NULL
Cell	NULL
Lines	NULL
Normalized	NULL
CAT	NULL
Activity	NULL
Plasmids	NULL
729	NULL
HELA	NULL
Jurkat	NULL
pCATBasic	NULL
1	NULL
1	NULL
1	NULL
pCAThuB29	NULL
(	NULL
-796	NULL
)	NULL
17	NULL
x	NULL
0.3	NULL
1	NULL
+	NULL
0.9	NULL
1.6	NULL
+	NULL
0.5	NULL
pCAThuB29	NULL
(	NULL
-	NULL
194	NULL
)	NULL
16.2	NULL
+	NULL
4.8	NULL
2.2	NULL
*	NULL
1.2	NULL
2.3	NULL
%	NULL
13	NULL
Mean	NULL
induction	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
by	NULL
the	NULL
B29	NULL
minimal	NULL
promoter	NULL
(	NULL
-193	NULL
)	NULL
and	NULL
upstream	NULL
sequences	NULL
(	NULL
-796	NULL
)	NULL
transfected	NULL
into	NULL
human	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
nonhematopoetic	NULL
HeLA	NULL
cells	NULL
shows	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
control	NULL
region	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

670	NULL
6	NULL
297	NULL
je	NULL
}	NULL
3	NULL
_	NULL
C	NULL
s	NULL
!	NULL

57	NULL
O	NULL
L1-	NULL
&	NULL
...	NULL
z	NULL
10-7	NULL
3G	NULL
<	NULL
4	NULL
L	NULL
;	NULL
|	NULL
0	NULL
57	NULL
o	NULL
pCAT	NULL
-532	NULL
-464	NULL
-464/	NULL
-193/	NULL
BCS	NULL
BCS	NULL
Fig	NULL
4	NULL
.	NULL

Transcriptional	NULL
analysis	NULL
of	NULL
the	NULL
B29	NULL
conserved	NULL
sequence	NULL
(	NULL
BCS	NULL
)	NULL
.	NULL

Double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
BCS	NULL
was	NULL
ligated	NULL
into	NULL
selected	NULL
CAT	NULL
constructs	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
on	NULL
CAT	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
relative	NULL
to	NULL
the	NULL
vector	NULL
alone	NULL
was	NULL
measured	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
CAT	NULL
induction	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
three	NULL
experi-ments	NULL
.	NULL

Reinsertion	NULL
of	NULL
the	NULL
BCS	NULL
sequences	NULL
into	NULL
the	NULL
-464	NULL
construct	NULL
from	NULL
which	NULL
it	NULL
had	NULL
been	NULL
deleted	NULL
resulted	NULL
in	NULL
CAT	NULL
activity	NULL
comparable	NULL
to	NULL
the	NULL
-532	NULL
construct	NULL
that	NULL
contains	NULL
the	NULL
sequences	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
BCS	NULL
on	NULL
increasing	NULL
CAT	NULL
activation	NULL
by	NULL
the	NULL
minimum	NULL
promoter	NULL
(	NULL
-193	NULL
)	NULL
is	NULL
less	NULL
dramatic	NULL
.	NULL

-193	NULL
promoter	NULL
(	NULL
-193/BCS	NULL
)	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
minimal	NULL
promoter	NULL
activity	NULL
(	NULL
-193	NULL
;	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
BCS	NULL
oligomer	NULL
to	NULL
the	NULL
-464	NULL
deletion	NULL
construct	NULL
increased	NULL
transcriptional	NULL
activity	NULL
fivefold	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
transcriptional	NULL
activity	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
-532	NULL
B29	NULL
gene	NULL
fragment	NULL
containing	NULL
the	NULL
BCS	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
BCS	NULL
was	NULL
equally	NULL
active	NULL
in	NULL
either	NULL
orientation	NULL
.	NULL

This	NULL
result	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
BCS	NULL
is	NULL
the	NULL
principal	NULL
active	NULL
element	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
sequences	NULL
from	NULL
-532	NULL
to	NULL
-464	NULL
.	NULL

These	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
BCS	NULL
acts	NULL
on	NULL
negative	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
-464	NULL
B29	NULL
gene	NULL
construct	NULL
rather	NULL
than	NULL
directly	NULL
on	NULL
the	NULL
193-bp	NULL
minimal	NULL
B29	NULL
promoter	NULL
.	NULL

BCS	NULL
factor	NULL
binding	NULL
studies	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
complexes	NULL
of	NULL
nuclear	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
BCS	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
a	NULL
double-stranded	NULL
synthetic	NULL
29-bp	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
BCS	NULL
sequence	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
697	NULL
pre-B	NULL
cells	NULL
,	NULL
8226	NULL
plasmacytoma	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
HL-60	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
the	NULL
end-labeled	NULL
BCS	NULL
oligonucleotide	NULL
probe	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
729	NULL
cells	NULL
resulted	NULL
in	NULL
retarded	NULL
mobility	NULL
of	NULL
a	NULL
doublet	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
this	NULL
interaction	NULL
was	NULL
established	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
BCS	NULL
oligonucleotide	NULL
that	NULL
resulted	NULL
in	NULL
the	NULL
incremental	NULL
loss	NULL
of	NULL
the	NULL
retarded	NULL
band	NULL
.	NULL

THOMPSON	NULL
ET	NULL
AL	NULL
An	NULL
excess	NULL
of	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
competitor	NULL
of	NULL
similar	NULL
size	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
BCS	NULL
binding	NULL
.	NULL

Studies	NULL
performed	NULL
on	NULL
697	NULL
pre-B	NULL
cells	NULL
and	NULL
H929	NULL
plasma	NULL
cells	NULL
gave	NULL
results	NULL
similar	NULL
to	NULL
those	NULL
with	NULL
729	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
8226	NULL
myeloma	NULL
cells	NULL
(	NULL
which	NULL
contain	NULL
no	NULL
detectable	NULL
B29	NULL
mRNA	NULL
)	NULL
yielded	NULL
only	NULL
nonspecific	NULL
binding	NULL
.	NULL

No	NULL
binding	NULL
was	NULL
detected	NULL
in	NULL
studies	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cells	NULL
.	NULL

Additional	NULL
assays	NULL
performed	NULL
with	NULL
a	NULL
radiolabeled	NULL
130-bp	NULL
genomic	NULL
DNA	NULL
fragment	NULL
that	NULL
contained	NULL
the	NULL
BCS	NULL
also	NULL
showed	NULL
specific	NULL
binding	NULL
and	NULL
competition	NULL
of	NULL
a	NULL
multibanded	NULL
complex	NULL
,	NULL
suggesting	NULL
that	NULL
sequences	NULL
adjacent	NULL
to	NULL
the	NULL
BCS	NULL
motif	NULL
may	NULL
contribute	NULL
to	NULL
nuclear	NULL
factor	NULL
binding	NULL
or	NULL
stability	NULL
.	NULL

These	NULL
EMSA	NULL
results	NULL
,	NULL
combined	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
expression	NULL
assays	NULL
,	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
BCS	NULL
is	NULL
an	NULL
important	NULL
regulatory	NULL
element	NULL
for	NULL
B29	NULL
gene	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
This	NULL
report	NULL
identifies	NULL
the	NULL
promoter	NULL
and	NULL
5	NULL
'	NULL
flanking	NULL
DNA	NULL
sequences	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
#	NULL
29	NULL
gene	NULL
.	NULL

The	NULL
human	NULL
#	NULL
29	NULL
minimal	NULL
promoter	NULL
is	NULL
contained	NULL
within	NULL
a	NULL
193-bp	NULL
DNA	NULL
fragment	NULL
that	NULL
strongly	NULL
stimulates	NULL
transcrip-	NULL
BCS	NULL
BCS	NULL
«	NULL
oct	NULL
50	NULL
125	NULL
500	NULL
250	NULL
Probe	NULL
Competitor	NULL
molar	NULL
excess	NULL
BCS	NULL
--	NULL
-	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
_	NULL
2	NULL
Fig	NULL
5	NULL
.	NULL

Competitive	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
the	NULL
BCS	NULL
binding	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
729	NULL
B	NULL
cells	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
10,000	NULL
cpm	NULL
of	NULL
a	NULL
radiolabeled	NULL
BCS	NULL
oligonucleotide	NULL
for	NULL
each	NULL
reaction	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
through	NULL
5	NULL
,	NULL
unlabeled	NULL
BCS	NULL
oligonucleotide	NULL
at	NULL
50	NULL
,	NULL
125	NULL
,	NULL
and	NULL
500	NULL
times	NULL
molar	NULL
excess	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
,	NULL
respectively	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
.	NULL

In	NULL
lane	NULL
6	NULL
,	NULL
50	NULL
ng	NULL
(	NULL
250	NULL
x	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
an	NULL
unrelated	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
oct	NULL
)	NULL
containing	NULL
an	NULL
octamer	NULL
motif	NULL
was	NULL
added	NULL
as	NULL
a	NULL
nonspecific	NULL
com-petitor	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HUMAN	NULL
829	NULL
PROMOTER	NULL
AND	NULL
5°	NULL
FLANKING	NULL
SEQUENCES	NULL
671	NULL
HUB23	NULL
GACCCC	NULL
AGCTGTGCTGCCCAAGCTGGGCGACCGC—-CAAACCTTAGCGGCCCAGCTGACAAAAGCCTG	NULL
MUB23	NULL
AACCCAAAGCTEI	NULL
’	NULL
GCTACCCAGGCAGGACCACC	NULL
CTTCGAGTCCTAGCAGACCAGCTGATG	NULL
AAG-CTG	NULL
IKAROS/LYF-1	NULL
OCT	NULL
ETS	NULL
HUB2Y	NULL
CCQKCQIAGGGTCCCCGGAGAGCTGGTGCCTCCCCTGGGTCCCAAIEIQCAIGGEAQQAAGGGGCCT	NULL
MUB23	NULL
CLGLCELAIAGGGTCCCTGGAGGGATGGTGCCTCCCCTGGGTCTCAAIELGSAIGGEAGQAAGGGGCCT	NULL
consensus	NULL
CCECCCAée	NULL
ATTTGCAT	NULL
-	NULL
GAGGAA	NULL
Fig	NULL
6	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
hu-	NULL
ETS	NULL
Spi	NULL
man	NULL
and	NULL
murine	NULL
B29	NULL
minimal	NULL
B	NULL
tal-	NULL
apecte	NULL
promoter	NULL
mean	NULL
.	NULL

-	NULL
MB20	NULL
scription	NULL
s	NULL
‘	NULL
lal	NULL
‘	NULL
t	NULL
sites	NULL
in	NULL
each	NULL
mre	NULL
-	NULL
000000	NULL
0	NULL
0	NULL
0	NULL
0	NULL
tt	NULL
t*	NULL
ttt	NULL
tt	NULL
6	NULL
t	NULL
6	NULL
6	NULL
t	NULL
e	NULL
6	NULL
k	NULL
e	NULL
s	NULL
6	NULL
t	NULL
k	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
owns	NULL
k	NULL
e	NULL
n	NULL
e	NULL
ce	NULL
6	NULL
e	NULL
e	NULL
ee	NULL
none	NULL
noted	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
numbering	NULL
_	NULL
MUB29	NULL
MTQGQQAAGAQQQQQAGAGGAGACAAGCTGCAGCCCAGGCTGACA	NULL
--	NULL
TACA	NULL
-GTTACATGTTTCGCCC	NULL
in	NULL
the	NULL
murine	NULL
promoter	NULL
is	NULL
from	NULL
_	NULL
CONSensus	NULL
GAGGAA	NULL
-	NULL
GGCGGG	NULL
the	NULL
dominant	NULL
start	NULL
site	NULL
deter	NULL
mined	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

Con	NULL
sensus	NULL
sequences	NULL
for	NULL
transcrip-	NULL
I—TT	NULL
’	NULL
I	NULL
``	NULL
tion	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
as	NULL
.	NULL

yug29	NULL
c	NULL
AAGGAGCCTCGGACGTI'GTCACGGGTYTGGGGTCGGGGACAGAGCAGTGACCALG	NULL
noted	NULL
.	NULL

Regions	NULL
surrounding	NULL
the	NULL
fiifPf	NULL
ff	NULL
fo	NULL
translation	NULL
initiation	NULL
site	NULL
factor	NULL
binding	NULL
sites	NULL
show	NULL
very	NULL
high	NULL
degrees	NULL
of	NULL
homology	NULL
.	NULL

tion	NULL
and	NULL
exhibits	NULL
B-cell-specific	NULL
expression	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

This	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
is	NULL
functionally	NULL
equivalent	NULL
to	NULL
the	NULL
previously	NULL
characterized	NULL
murine	NULL
829	NULL
minimal	NULL
promoter	NULL
.	NULL
``	NULL

Comparison	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
minimal	NULL
promoters	NULL
shows	NULL
a	NULL
striking	NULL
pattern	NULL
of	NULL
sequence	NULL
conservation	NULL
related	NULL
to	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
these	NULL
gene	NULL
segments	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

The	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
contains	NULL
two	NULL
regions	NULL
that	NULL
are	NULL
highly	NULL
conserved	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
murine	NULL
minimal	NULL
promoter	NULL
.	NULL

These	NULL
are	NULL
separated	NULL
by	NULL
an	NULL
intervening	NULL
segment	NULL
with	NULL
a	NULL
different	NULL
length	NULL
and	NULL
lower	NULL
sequence	NULL
conservation	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
murine	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
most	NULL
highly	NULL
conserved	NULL
region	NULL
in	NULL
the	NULL
human	NULL
promoter	NULL
(	NULL
ie	NULL
,	NULL
-23	NULL
to	NULL
-34	NULL
)	NULL
is	NULL
91	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
murine	NULL
B29	NULL
promoter	NULL
sequence	NULL
(	NULL
ie	NULL
,	NULL
-48	NULL
to	NULL
-158	NULL
)	NULL
that	NULL
contains	NULL
all	NULL
the	NULL
transcription	NULL
control	NULL
motifs	NULL
determined	NULL
to	NULL
control	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
promoter	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

The	NULL
ATTTGCAT	NULL
at	NULL
-74	NULL
exactly	NULL
matches	NULL
the	NULL
murine	NULL
£29	NULL
octamer	NULL
motif	NULL
(	NULL
OCT	NULL
)	NULL
and	NULL
the	NULL
canonical	NULL
OCT	NULL
motifs	NULL
in	NULL
Ig	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
gene	NULL
promoters	NULL
and	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
intron	NULL
enhancer	NULL
.	NULL
``	NULL

Mutation	NULL
of	NULL
this	NULL
motif	NULL
in	NULL
the	NULL
murine	NULL
promoter	NULL
completely	NULL
abolished	NULL
transcriptional	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
The	NULL
two	NULL
ETS	NULL
boxes	NULL
(	NULL
CAG-GAA	NULL
and	NULL
GAGGAA	NULL
)	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
OCT	NULL
are	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
macrophage	NULL
and	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
as	NULL
well	NULL
as	NULL
other	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
oncogene	NULL
family	NULL
.	NULL
``	NULL

''	NULL
A	NULL
single	NULL
consensus	NULL
motif	NULL
for	NULL
SP1	NULL
(	NULL
GGCGGG	NULL
)	NULL
is	NULL
located	NULL
at	NULL
position	NULL
-42	NULL
.	NULL

The	NULL
CCTCCC-CCA	NULL
sequence	NULL
at	NULL
-	NULL
118	NULL
closely	NULL
corresponds	NULL
to	NULL
the	NULL
consensus	NULL
motif	NULL
for	NULL
IKAROS/LYF-1	NULL
family	NULL
members	NULL
that	NULL
are	NULL
known	NULL
to	NULL
control	NULL
lymphocyte	NULL
gene	NULL
expression	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
Mutations	NULL
in	NULL
the	NULL
SP1	NULL
,	NULL
ETS	NULL
,	NULL
and	NULL
IKAROS/LYF-1	NULL
motifs	NULL
all	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
minimal	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
region	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
IKAROS/LYF-1	NULL
motif	NULL
(	NULL
ie	NULL
,	NULL
-126	NULL
to	NULL
-138	NULL
)	NULL
also	NULL
contributed	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
B29	NULL
minimal	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
in	NULL
vitro	NULL
footprint	NULL
with	NULL
purified	NULL
LYF-1	NULL
extended	NULL
CCAAA	NULL
--	NULL
-CCTCc	NULL
--	NULL
-L	NULL
»	NULL
Lp	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
TTGGGCTCﬁAGACAGAGCAGTGACCALQ	NULL
+1	NULL
through	NULL
this	NULL
region	NULL
and	NULL
this	NULL
sequence	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
promoter	NULL
sequence	NULL
.	NULL

The	NULL
region	NULL
(	NULL
ie	NULL
,	NULL
-22	NULL
to	NULL
+	NULL
27	NULL
)	NULL
containing	NULL
the	NULL
mapped	NULL
human	NULL
B29	NULL
transcription	NULL
start	NULL
sites	NULL
exhibits	NULL
approximately	NULL
60	NULL
%	NULL
identity	NULL
(	NULL
incorporating	NULL
numerous	NULL
gaps	NULL
)	NULL
to	NULL
the	NULL
corresponding	NULL
murine	NULL
B29	NULL
promoter	NULL
sequence	NULL
(	NULL
ie	NULL
,	NULL
nucleotides	NULL
-8	NULL
to	NULL
-47	NULL
;	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

The	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
lacks	NULL
a	NULL
TATA	NULL
box	NULL
and	NULL
transcription	NULL
is	NULL
initiated	NULL
at	NULL
5	NULL
sites	NULL
located	NULL
44	NULL
to	NULL
53	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
codon	NULL
.	NULL

The	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
the	NULL
murine	NULL
B29	NULL
promoter	NULL
are	NULL
more	NULL
broadly	NULL
distributed	NULL
and	NULL
lie	NULL
12	NULL
to	NULL
33	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
codon	NULL
.	NULL

Neither	NULL
the	NULL
location	NULL
nor	NULL
spacing	NULL
of	NULL
transcription	NULL
start	NULL
sites	NULL
is	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
sequences	NULL
.	NULL

The	NULL
murine	NULL
sites	NULL
only	NULL
partially	NULL
overlap	NULL
those	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
.	NULL

Multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
have	NULL
now	NULL
been	NULL
described	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
TATA-less	NULL
lymphocyte-specific	NULL
genes	NULL
,	NULL
including	NULL
mb-7	NULL
,	NULL
``	NULL
``	NULL
the	NULL
surrogate	NULL
light	NULL
chains	NULL
A5	NULL
``	NULL
and	NULL
Vpre-B	NULL
.	NULL
``	NULL

CD7	NULL
,	NULL
*	NULL
``	NULL
CD11a	NULL
,	NULL
*	NULL
CD18	NULL
,	NULL
``	NULL
CD19	NULL
,	NULL
*	NULL
and	NULL
CD22	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
how	NULL
transcription	NULL
initiations	NULL
are	NULL
determined	NULL
in	NULL
these	NULL
genes	NULL
.	NULL

TATA-less	NULL
,	NULL
GC-rich	NULL
promoters	NULL
in	NULL
constitutively	NULL
expressed	NULL
housekeeping	NULL
genes	NULL
exhibit	NULL
multiple	NULL
transcription	NULL
starts	NULL
40	NULL
to	NULL
80	NULL
bp	NULL
downstream	NULL
of	NULL
multiple	NULL
SP1	NULL
motifs	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
the	NULL
multiple	NULL
start	NULL
sites	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
promoters	NULL
are	NULL
located	NULL
40	NULL
to	NULL
80	NULL
bp	NULL
downstream	NULL
of	NULL
lone	NULL
SP1	NULL
motifs	NULL
.	NULL

The	NULL
second	NULL
region	NULL
of	NULL
high	NULL
sequence	NULL
conservation	NULL
in	NULL
the	NULL
human	NULL
B29	NULL
minimal	NULL
promoter	NULL
(	NULL
ie	NULL
,	NULL
+28	NULL
to	NULL
+53	NULL
)	NULL
is	NULL
88	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
homologous	NULL
murine	NULL
sequence	NULL
(	NULL
ie	NULL
,	NULL
to	NULL
+19	NULL
;	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

This	NULL
region	NULL
comprises	NULL
26	NULL
bp	NULL
of	NULL
5'-untranslated	NULL
(	NULL
5'-UT	NULL
)	NULL
region	NULL
directly	NULL
preceding	NULL
the	NULL
ATG	NULL
codon	NULL
.	NULL

It	NULL
is	NULL
notable	NULL
that	NULL
the	NULL
sequence	NULL
conservation	NULL
in	NULL
this	NULL
region	NULL
is	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
the	NULL
leader	NULL
coding	NULL
sequence	NULL
.	NULL

The	NULL
function	NULL
of	NULL
this	NULL
highly	NULL
conserved	NULL
5	NULL
``	NULL
-UT	NULL
sequence	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
Kozak	NULL
box	NULL
directly	NULL
preceding	NULL
the	NULL
ATG	NULL
codon	NULL
is	NULL
the	NULL
only	NULL
known	NULL
functional	NULL
element	NULL
in	NULL
this	NULL
sequence	NULL
.	NULL

This	NULL
region	NULL
in	NULL
the	NULL
mu	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

672	NULL
rine	NULL
B29	NULL
sequence	NULL
contains	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
and	NULL
a	NULL
minor	NULL
start	NULL
site	NULL
(	NULL
+8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
locations	NULL
of	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
genes	NULL
do	NULL
not	NULL
exhibit	NULL
any	NULL
discernable	NULL
spatial	NULL
relationship	NULL
to	NULL
this	NULL
highly	NULL
conserved	NULL
sequence	NULL
.	NULL

The	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
B29	NULL
minimal	NULL
promoter	NULL
apparently	NULL
contains	NULL
multiple	NULL
elements	NULL
that	NULL
stimulate	NULL
and	NULL
inhibit	NULL
B29	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
quite	NULL
substantial	NULL
loss	NULL
in	NULL
transcription	NULL
activity	NULL
(	NULL
ie	NULL
,	NULL
15-fold	NULL
)	NULL
seen	NULL
with	NULL
5	NULL
deletions	NULL
from	NULL
-796	NULL
to	NULL
-464	NULL
suggests	NULL
that	NULL
this	NULL
region	NULL
contains	NULL
multiple	NULL
elements	NULL
that	NULL
exert	NULL
positive	NULL
influences	NULL
on	NULL
the	NULL
829	NULL
minimal	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
-464	NULL
fragment	NULL
appears	NULL
to	NULL
contain	NULL
sequences	NULL
that	NULL
exert	NULL
a	NULL
powerful	NULL
dominant	NULL
negative	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
downstream	NULL
B29	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
construct	NULL
-464	NULL
was	NULL
15-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
829	NULL
minimal	NULL
promoter	NULL
in	NULL
B-lineage	NULL
cells	NULL
.	NULL

Negative	NULL
regulatory	NULL
elements	NULL
may	NULL
extend	NULL
into	NULL
the	NULL
DNA	NULL
fragment	NULL
ending	NULL
at	NULL
-304	NULL
,	NULL
which	NULL
showed	NULL
less	NULL
activity	NULL
than	NULL
the	NULL
829	NULL
minimal	NULL
promoter	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
functional	NULL
expression	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
£29	NULL
minimal	NULL
promoter	NULL
contains	NULL
a	NULL
complex	NULL
array	NULL
of	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
transcription	NULL
control	NULL
elements	NULL
.	NULL

Studies	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
identify	NULL
the	NULL
functional	NULL
elements	NULL
in	NULL
this	NULL
region	NULL
and	NULL
to	NULL
determine	NULL
if	NULL
they	NULL
collectively	NULL
function	NULL
as	NULL
enhancers	NULL
or	NULL
silencers	NULL
controlling	NULL
B29	NULL
gene	NULL
specificity	NULL
and	NULL
expression	NULL
.	NULL

One	NULL
positive	NULL
5	NULL
'	NULL
regulatory	NULL
element	NULL
,	NULL
initially	NULL
identified	NULL
by	NULL
its	NULL
high	NULL
sequence	NULL
conservation	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
B29	NULL
5	NULL
regions	NULL
,	NULL
is	NULL
the	NULL
BCS	NULL
.	NULL

The	NULL
BCS	NULL
is	NULL
located	NULL
in	NULL
an	NULL
upstream	NULL
region	NULL
which	NULL
stimulates	NULL
B29	NULL
transcription	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
5	NULL
'	NULL
segment	NULL
containing	NULL
the	NULL
BCS	NULL
(	NULL
ie	NULL
,	NULL
-532	NULL
to	NULL
-464	NULL
)	NULL
produced	NULL
a	NULL
fivefold	NULL
decrease	NULL
in	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
BCS	NULL
does	NULL
not	NULL
resemble	NULL
any	NULL
known	NULL
transcription	NULL
factor	NULL
motif	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
may	NULL
represent	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
effects	NULL
of	NULL
an	NULL
isolated	NULL
BCS	NULL
on	NULL
either	NULL
homologous	NULL
or	NULL
heterologous	NULL
promoters	NULL
and	NULL
on	NULL
the	NULL
-464	NULL
B29	NULL
gene	NULL
segment	NULL
confirm	NULL
this	NULL
suggestion	NULL
.	NULL

A	NULL
single	NULL
29-bp	NULL
BCS	NULL
element	NULL
had	NULL
only	NULL
minimal	NULL
effects	NULL
(	NULL
<	NULL
2-fold	NULL
)	NULL
on	NULL
the	NULL
193-bp	NULL
B29	NULL
minimal	NULL
promoter	NULL
or	NULL
a	NULL
56-bp	NULL
c-fos	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
insertion	NULL
of	NULL
a	NULL
single	NULL
BCS	NULL
upstream	NULL
of	NULL
the	NULL
-464	NULL
construct	NULL
increased	NULL
transcriptional	NULL
activity	NULL
to	NULL
the	NULL
level	NULL
seen	NULL
with	NULL
the	NULL
-532	NULL
construct	NULL
containing	NULL
the	NULL
BCS	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
BCS	NULL
stimulates	NULL
transcription	NULL
by	NULL
counteracting	NULL
nearby	NULL
negative	NULL
regulatory	NULL
elements	NULL
rather	NULL
than	NULL
by	NULL
acting	NULL
directly	NULL
on	NULL
the	NULL
B29	NULL
promoter	NULL
.	NULL

A	NULL
similar	NULL
mode	NULL
of	NULL
regulation	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
the	NULL
x	NULL
intron	NULL
enhancer	NULL
in	NULL
which	NULL
the	NULL
inhibitory	NULL
activity	NULL
of	NULL
a	NULL
27-bp	NULL
negative	NULL
segment	NULL
(	NULL
«	NULL
NE	NULL
)	NULL
was	NULL
prevented	NULL
by	NULL
an	NULL
adjacent	NULL
30-bp	NULL
positive	NULL
segment	NULL
(	NULL
«	NULL
BS	NULL
)	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
dimerized	NULL
x	NULL
BS	NULL
segments	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL
``	NULL

Like	NULL
the	NULL
BCS	NULL
,	NULL
the	NULL
«	NULL
BS	NULL
apparently	NULL
lacks	NULL
significant	NULL
transcriptional	NULL
activity	NULL
outside	NULL
of	NULL
its	NULL
context	NULL
in	NULL
the	NULL
x	NULL
intron	NULL
enhancer	NULL
.	NULL

The	NULL
stimulatory	NULL
activity	NULL
of	NULL
the	NULL
BCS	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
specific	NULL
nuclear	NULL
proteins	NULL
.	NULL

Specific	NULL
nuclear	NULL
protein	NULL
complexes	NULL
were	NULL
readily	NULL
detected	NULL
in	NULL
EMSA	NULL
using	NULL
a	NULL
29-bp	NULL
oligomer	NULL
BCS	NULL
.	NULL

Specific	NULL
competition	NULL
with	NULL
the	NULL
BCS	NULL
oligomer	NULL
establishes	NULL
that	NULL
this	NULL
sequence	NULL
is	NULL
bound	NULL
by	NULL
proteins	NULL
in	NULL
the	NULL
complexes	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
additional	NULL
sequences	NULL
in	NULL
the	NULL
130-bp	NULL
DNA	NULL
fragment	NULL
may	NULL
be	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
or	NULL
stabilization	NULL
of	NULL
the	NULL
BCS-binding	NULL
protein	NULL
complexes	NULL
.	NULL

The	NULL
BCS-binding	NULL
activ-	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
ity	NULL
was	NULL
tissue-specific	NULL
and	NULL
was	NULL
detectable	NULL
at	NULL
all	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
BCS	NULL
complex	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
the	NULL
RPMI	NULL
8226	NULL
myeloma	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
express	NULL
B29	NULL
mRNA	NULL
.	NULL

This	NULL
report	NULL
continues	NULL
our	NULL
exploration	NULL
of	NULL
the	NULL
human	NULL
B29	NULL
gene	NULL
and	NULL
increases	NULL
our	NULL
understanding	NULL
of	NULL
its	NULL
regulation	NULL
.	NULL

This	NULL
gene	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
display	NULL
of	NULL
membrane	NULL
Ig	NULL
and	NULL
in	NULL
signal	NULL
transduction	NULL
and	NULL
B-cell	NULL
activation	NULL
through	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
.	NULL

Resolution	NULL
of	NULL
the	NULL
molecular	NULL
features	NULL
regulating	NULL
B29	NULL
gene	NULL
expression	NULL
should	NULL
provide	NULL
insights	NULL
into	NULL
potential	NULL
mechanisms	NULL
for	NULL
disease	NULL
states	NULL
resulting	NULL
from	NULL
abnormal	NULL
antigen	NULL
receptor	NULL
complex	NULL
expression	NULL
or	NULL
function	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Van	NULL
Noesel	NULL
CJM	NULL
,	NULL
van	NULL
Lier	NULL
RAW	NULL
:	NULL
Architecture	NULL
of	NULL
the	NULL
human	NULL
B-cell	NULL
antigen	NULL
receptors	NULL
.	NULL

Blood	NULL
82:363	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Reth	NULL
M	NULL
,	NULL
Hombach	NULL
J	NULL
,	NULL
Wienands	NULL
J	NULL
,	NULL
Campbell	NULL
KS	NULL
,	NULL
Chien	NULL
N	NULL
,	NULL
Justement	NULL
LB	NULL
,	NULL
Cambier	NULL
JC	NULL
:	NULL
The	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
.	NULL

Immunol	NULL
Today	NULL
12:196	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Venkitaraman	NULL
AR	NULL
,	NULL
Williams	NULL
GT	NULL
,	NULL
Dariavach	NULL
P	NULL
,	NULL
Neuberger	NULL
MS	NULL
:	NULL
The	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
of	NULL
the	NULL
five	NULL
immunoglobulin	NULL
classes	NULL
.	NULL

Nature	NULL
352:777	NULL
,	NULL
1991	NULL
4	NULL
.	NULL

Lankester	NULL
AC	NULL
,	NULL
van	NULL
Schinjindel	NULL
GMW	NULL
,	NULL
Fromme	NULL
J	NULL
,	NULL
Cordell	NULL
JL	NULL
,	NULL
van	NULL
Liet	NULL
RAW	NULL
,	NULL
van	NULL
Noesel	NULL
CJM	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
direct	NULL
physical	NULL
interaction	NULL
of	NULL
membrane	NULL
IgM	NULL
,	NULL
IgD	NULL
,	NULL
and	NULL
IgG	NULL
with	NULL
the	NULL
B29	NULL
gene	NULL
product	NULL
.	NULL

J	NULL
Immunol	NULL
152:2157	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Van	NULL
Noesel	NULL
CJM	NULL
,	NULL
Brouns	NULL
GS	NULL
,	NULL
van	NULL
Schijndel	NULL
GMW	NULL
,	NULL
Bende	NULL
RJ	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Borst	NULL
J	NULL
,	NULL
van	NULL
Lie	NULL
RAW	NULL
:	NULL
Comparison	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
complexes	NULL
:	NULL
Membrane-expressed	NULL
forms	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
M	NULL
,	NULL
IgD	NULL
,	NULL
and	NULL
IgG	NULL
are	NULL
associated	NULL
with	NULL
structurally	NULL
related	NULL
heterodimers	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:1511	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Campbell	NULL
KS	NULL
,	NULL
Hager	NULL
EJ	NULL
,	NULL
Friedrich	NULL
RJ	NULL
,	NULL
Cambier	NULL
JC	NULL
:	NULL
IgM	NULL
antigen	NULL
receptor	NULL
complex	NULL
contains	NULL
phosphoprotein	NULL
products	NULL
of	NULL
B29	NULL
and	NULL
mb-1	NULL
genes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:3982	NULL
,	NULL
1991	NULL
7	NULL
.	NULL

Grupp	NULL
SA	NULL
,	NULL
Campbell	NULL
KS	NULL
,	NULL
Mitchell	NULL
RN	NULL
,	NULL
Cambier	NULL
JC	NULL
,	NULL
Abbas	NULL
AK	NULL
:	NULL
Signalling-defective	NULL
mutants	NULL
of	NULL
the	NULL
B	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
fail	NULL
to	NULL
associate	NULL
with	NULL
Iga	NULL
and	NULL
J	NULL
Biol	NULL
Chem	NULL
268:25776	NULL
,	NULL
1993	NULL
8	NULL
.	NULL

Sanchez	NULL
M	NULL
,	NULL
Misulovin	NULL
Z	NULL
,	NULL
Burkhardt	NULL
AL	NULL
,	NULL
Mahajan	NULL
S	NULL
,	NULL
Costa	NULL
T	NULL
,	NULL
Franke	NULL
R	NULL
,	NULL
Bolen	NULL
JB	NULL
,	NULL
Nussenweig	NULL
M	NULL
:	NULL
Signal	NULL
transduction	NULL
by	NULL
immunoglobulin	NULL
is	NULL
mediated	NULL
through	NULL
Iga	NULL
and	NULL
Ig	NULL
#	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
178:1049	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Ishihara	NULL
K	NULL
,	NULL
Wood	NULL
WJ	NULL
,	NULL
Damore	NULL
M	NULL
,	NULL
Hermanson	NULL
GG	NULL
,	NULL
Wall	NULL
R	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
B29	NULL
gene	NULL
products	NULL
complex	NULL
with	NULL
immunoglobulins	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:633	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Matsuuchi	NULL
L	NULL
,	NULL
Gold	NULL
MR	NULL
,	NULL
Travis	NULL
A	NULL
,	NULL
Grosschedl	NULL
R	NULL
,	NULL
DeFranco	NULL
AL	NULL
,	NULL
Kelly	NULL
RB	NULL
:	NULL
The	NULL
membrane	NULL
IgM-associated	NULL
proteins	NULL
mb-1	NULL
and	NULL
B29	NULL
are	NULL
sufficient	NULL
to	NULL
promote	NULL
surface	NULL
expression	NULL
of	NULL
a	NULL
partially	NULL
functional	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
in	NULL
a	NULL
nonlymphoid	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
USA	NULL
89:3404	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Costa	NULL
TE	NULL
,	NULL
Franke	NULL
RR	NULL
,	NULL
Sanchez	NULL
M	NULL
,	NULL
Misulovin	NULL
Z	NULL
,	NULL
Nussenweig	NULL
MC	NULL
:	NULL
Functional	NULL
reconstitution	NULL
of	NULL
an	NULL
immunoglobulin	NULL
antigen	NULL
receptor	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:1669	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Burkhardt	NULL
AL	NULL
,	NULL
Costa	NULL
T	NULL
,	NULL
Misulovin	NULL
Z	NULL
,	NULL
Stealy	NULL
B	NULL
,	NULL
Bolen	NULL
JB	NULL
,	NULL
Nussenweig	NULL
MC	NULL
:	NULL
Iga	NULL
and	NULL
Igo	NULL
are	NULL
functionally	NULL
homologous	NULL
to	NULL
the	NULL
signalling	NULL
proteins	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1095	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Reth	NULL
M	NULL
:	NULL
Antigen	NULL
receptor	NULL
tail	NULL
clue	NULL
.	NULL

Nature	NULL
338:383	NULL
,	NULL
1989	NULL
14	NULL
.	NULL

Wilson	NULL
GL	NULL
,	NULL
Najfeld	NULL
V	NULL
,	NULL
Kozlow	NULL
E	NULL
,	NULL
Menninger	NULL
J	NULL
,	NULL
Ward	NULL
D	NULL
,	NULL
Kehrl	NULL
JH	NULL
:	NULL
Genomic	NULL
structure	NULL
and	NULL
chromosomal	NULL
mapping	NULL
of	NULL
the	NULL
human	NULL
CD22	NULL
gene	NULL
.	NULL

J	NULL
Immunol	NULL
11:5013	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Clark	NULL
MR	NULL
,	NULL
Campbell	NULL
KS	NULL
,	NULL
Kazlaukas	NULL
A	NULL
,	NULL
Johnson	NULL
SA	NULL
,	NULL
Hertz	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HUMAN	NULL
B29	NULL
PROMOTER	NULL
AND	NULL
5°	NULL
FLANKING	NULL
SEQUENCES	NULL
M	NULL
,	NULL
Potter	NULL
TA	NULL
,	NULL
Pleiman	NULL
C	NULL
,	NULL
Cambier	NULL
JC	NULL
:	NULL
The	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
:	NULL
Association	NULL
of	NULL
Iga	NULL
and	NULL
Ig	NULL
#	NULL
with	NULL
distinct	NULL
cytoplasmic	NULL
ef-fectors	NULL
.	NULL

Science	NULL
258:123	NULL
,	NULL
1992	NULL
16	NULL
.	NULL

Lin	NULL
J	NULL
,	NULL
Justement	NULL
LB	NULL
:	NULL
The	NULL
mb-1/B29	NULL
heterodimer	NULL
couples	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
multiple	NULL
src	NULL
family	NULL
protein	NULL
tyrosine	NULL
ki-nases	NULL
.	NULL

J	NULL
Immunol	NULL
149:1548	NULL
,	NULL
1992	NULL
17	NULL
.	NULL

Hagman	NULL
J	NULL
,	NULL
Grosschedl	NULL
R	NULL
:	NULL
Regulation	NULL
of	NULL
gene	NULL
expression	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
6:222	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Hermanson	NULL
GG	NULL
,	NULL
Eisenberg	NULL
D	NULL
,	NULL
Kincade	NULL
PW	NULL
,	NULL
Wall	NULL
R	NULL
:	NULL
B29	NULL
:	NULL
A	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
superfamily	NULL
exclusively	NULL
expressed	NULL
on	NULL
B-lineage	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:6890	NULL
,	NULL
1988	NULL
19	NULL
.	NULL

Hashimoto	NULL
S	NULL
,	NULL
Gregersen	NULL
PK	NULL
,	NULL
Chiorazzi	NULL
N	NULL
:	NULL
The	NULL
human	NULL
Ig-	NULL
#	NULL
cDNA	NULL
sequence	NULL
,	NULL
a	NULL
homologue	NULL
of	NULL
murine	NULL
B29	NULL
,	NULL
is	NULL
identical	NULL
in	NULL
B	NULL
cell	NULL
and	NULL
plasma	NULL
cell	NULL
lines	NULL
producine	NULL
all	NULL
the	NULL
human	NULL
Ig	NULL
isotypes	NULL
.	NULL

J	NULL
Immunol	NULL
150:491	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
van	NULL
Noesel	NULL
CJM	NULL
,	NULL
Cordell	NULL
JL	NULL
,	NULL
Comans-Bitter	NULL
WM	NULL
,	NULL
Micklem	NULL
K	NULL
,	NULL
Tse	NULL
AGD	NULL
,	NULL
van	NULL
Lier	NULL
RAW	NULL
,	NULL
van	NULL
Dongen	NULL
JJM	NULL
:	NULL
The	NULL
B29	NULL
and	NULL
mb-1	NULL
polypeptides	NULL
are	NULL
differentially	NULL
expressed	NULL
during	NULL
human	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
22:2753	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Kuzu	NULL
I	NULL
,	NULL
Jones	NULL
M	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
Ig-associated	NULL
heterodimer	NULL
(	NULL
mb-1	NULL
and	NULL
B29	NULL
)	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Histopathology	NULL
22:141	NULL
,	NULL
1993	NULL
22	NULL
.	NULL

Hermanson	NULL
GG	NULL
,	NULL
Briskin	NULL
M	NULL
,	NULL
Sigman	NULL
D	NULL
,	NULL
Wall	NULL
R	NULL
:	NULL
Immunoglobulin	NULL
enhancer	NULL
and	NULL
promoter	NULL
motifs	NULL
5	NULL
'	NULL
of	NULL
the	NULL
B29	NULL
B-cell-specific	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:7341	NULL
,	NULL
1989	NULL
23	NULL
.	NULL

Omori	NULL
SA	NULL
,	NULL
Wall	NULL
R	NULL
:	NULL
Multiple	NULL
motifs	NULL
regulate	NULL
the	NULL
B-cell-specific	NULL
promoter	NULL
of	NULL
the	NULL
B29	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:11723	NULL
,	NULL
1993	NULL
24	NULL
.	NULL

Wood	NULL
WJ	NULL
,	NULL
Thompson	NULL
AA	NULL
,	NULL
Korenberg	NULL
J	NULL
,	NULL
Chen	NULL
X-N	NULL
,	NULL
May	NULL
W	NULL
,	NULL
Wall	NULL
R	NULL
,	NULL
Denny	NULL
CT	NULL
:	NULL
Isolation	NULL
and	NULL
chromosomal	NULL
mapping	NULL
of	NULL
the	NULL
human	NULL
immunoglobulin-associated	NULL
B29	NULL
gene	NULL
(	NULL
Ig	NULL
#	NULL
)	NULL
.	NULL

Genomics	NULL
16:187	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Hashimoto	NULL
S	NULL
,	NULL
Chiorazzi	NULL
N	NULL
,	NULL
Gregersen	NULL
PK	NULL
:	NULL
The	NULL
complete	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
CD79b	NULL
(	NULL
IgA/B29	NULL
)	NULL
gene	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
conserved	NULL
exon/intron	NULL
organization	NULL
,	NULL
immunoglobulin-like	NULL
regulatory	NULL
regions	NULL
,	NULL
and	NULL
allelic	NULL
polymorphism	NULL
.	NULL

Immunogenetics	NULL
40:145	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Gilman	NULL
MZ	NULL
,	NULL
Wilson	NULL
RN	NULL
,	NULL
Weinberg	NULL
RA	NULL
:	NULL
Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
6:4305	NULL
,	NULL
1986	NULL
27	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebovits	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
28	NULL
.	NULL

Verschuren	NULL
MCM	NULL
,	NULL
Comans-Bitter	NULL
WM	NULL
,	NULL
Kapteijn	NULL
CAC	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Brouns	NULL
GS	NULL
,	NULL
Borst	NULL
J	NULL
,	NULL
Drexler	NULL
HG	NULL
,	NULL
van	NULL
Dongen	NULL
JJM	NULL
:	NULL
Transcription	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
mb-l	NULL
and	NULL
B29	NULL
genes	NULL
in	NULL
human	NULL
hematopoietic	NULL
malignancies	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Leukemia	NULL
7:1939	NULL
,	NULL
1993	NULL
29	NULL
.	NULL

Parslow	NULL
TG	NULL
,	NULL
Blair	NULL
DL	NULL
,	NULL
Murphy	NULL
WJ	NULL
,	NULL
Granner	NULL
DK	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
:	NULL
A	NULL
novel	NULL
conserved	NULL
sequence	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:2650	NULL
,	NULL
1984	NULL
673	NULL
30	NULL
.	NULL

Falkner	NULL
FG	NULL
,	NULL
Zachau	NULL
HG	NULL
:	NULL
Correct	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
kappa	NULL
gene	NULL
requires	NULL
an	NULL
upstream	NULL
fragment	NULL
containing	NULL
conserved	NULL
sequence	NULL
elements	NULL
.	NULL

Nature	NULL
310:71	NULL
,	NULL
1984	NULL
31	NULL
.	NULL

Klemsz	NULL
MJ	NULL
,	NULL
McKercher	NULL
SR	NULL
,	NULL
Celada	NULL
A	NULL
,	NULL
Van	NULL
Beveren	NULL
C	NULL
,	NULL
Maki	NULL
RA	NULL
:	NULL
The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113	NULL
,	NULL
1990	NULL
32	NULL
.	NULL

Goebl	NULL
MG	NULL
:	NULL
The	NULL
PU.1	NULL
transcription	NULL
factor	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
putative	NULL
oncogene	NULL
Spi-1	NULL
.	NULL

Cell	NULL
61:1165	NULL
,	NULL
1990	NULL
33	NULL
.	NULL

Nelson	NULL
B	NULL
,	NULL
Tian	NULL
G	NULL
,	NULL
Erman	NULL
B	NULL
,	NULL
Gregoire	NULL
J	NULL
,	NULL
Maki	NULL
R	NULL
,	NULL
Graves	NULL
B	NULL
,	NULL
Sen	NULL
R	NULL
:	NULL
Regulation	NULL
of	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
L	NULL
heavy	NULL
chain	NULL
enhancer	NULL
by	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

Science	NULL
261:82	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Molnar	NULL
A	NULL
,	NULL
Georgopoulos	NULL
K	NULL
:	NULL
The	NULL
Ikaros	NULL
gene	NULL
encodes	NULL
a	NULL
family	NULL
of	NULL
functionally	NULL
diverse	NULL
zinc	NULL
finger	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:8292	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

Lo	NULL
K	NULL
,	NULL
Landau	NULL
NR	NULL
,	NULL
Smale	NULL
ST	NULL
:	NULL
Lyf-1	NULL
,	NULL
a	NULL
transcriptional	NULL
regulator	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
promoters	NULL
for	NULL
lymphocyte-specific	NULL
genes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:5229	NULL
,	NULL
1991	NULL
36	NULL
.	NULL

Thompson	NULL
AA	NULL
,	NULL
Omori	NULL
S	NULL
,	NULL
Wall	NULL
R	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
immunoglobulin	NULL
associated	NULL
B29	NULL
genes	NULL
.	NULL

Blood	NULL
80:55a	NULL
,	NULL
1992	NULL
(	NULL
abstr	NULL
,	NULL
suppl	NULL
1	NULL
)	NULL
37	NULL
.	NULL

Smale	NULL
ST	NULL
:	NULL
Core	NULL
promoter	NULL
architecture	NULL
for	NULL
eukaryotic	NULL
protein-coding	NULL
genes	NULL
,	NULL
in	NULL
Conway	NULL
RC	NULL
,	NULL
Conway	NULL
JW	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Transcription	NULL
:	NULL
Mechanisms	NULL
and	NULL
Regulation	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Raven	NULL
,	NULL
1994	NULL
,	NULL
p	NULL
63	NULL
38	NULL
.	NULL

Travis	NULL
A	NULL
,	NULL
Hagman	NULL
J	NULL
,	NULL
Groschedl	NULL
R	NULL
:	NULL
;	NULL
Heterogenously	NULL
initiated	NULL
transcription	NULL
from	NULL
the	NULL
preB-	NULL
and	NULL
B-cell-specific	NULL
mb-1	NULL
promoter	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
requirement	NULL
for	NULL
upstream	NULL
factor-binding	NULL
sites	NULL
and	NULL
initiation	NULL
site	NULL
sequences	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:5756	NULL
,	NULL
1991	NULL
39	NULL
.	NULL

Kudo	NULL
A	NULL
,	NULL
Sakaguchi	NULL
N	NULL
,	NULL
Melchers	NULL
F	NULL
:	NULL
Organization	NULL
of	NULL
the	NULL
murine	NULL
Ig-related	NULL
A	NULL
,	NULL
gene	NULL
transcribed	NULL
selectively	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
6:103	NULL
,	NULL
1987	NULL
40	NULL
.	NULL

Kudo	NULL
A	NULL
,	NULL
Melchers	NULL
F	NULL
:	NULL
A	NULL
second	NULL
gene	NULL
VpreB	NULL
in	NULL
the	NULL
As	NULL
locus	NULL
of	NULL
the	NULL
mouse	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
selectively	NULL
expressed	NULL
in	NULL
pre-B	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
6:2267	NULL
,	NULL
1987	NULL
41	NULL
.	NULL

Schanberg	NULL
LE	NULL
,	NULL
Fleenor	NULL
DE	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Kaufman	NULL
RE	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
genomic	NULL
human	NULL
CD7	NULL
gene	NULL
:	NULL
Structural	NULL
similarity	NULL
with	NULL
the	NULL
murine	NULL
Thy-1	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:603	NULL
,	NULL
1991	NULL
42	NULL
.	NULL

Nueda	NULL
A	NULL
,	NULL
Lopez-Cabreras	NULL
M	NULL
,	NULL
Vara	NULL
A	NULL
,	NULL
Corbi	NULL
AL	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
CDlla	NULL
integrin	NULL
gene	NULL
promoter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:19305	NULL
,	NULL
1993	NULL
43	NULL
.	NULL

Agura	NULL
ED	NULL
,	NULL
Howard	NULL
M	NULL
,	NULL
Collins	NULL
SJ	NULL
;	NULL
Identification	NULL
and	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
the	NULL
leukocyte	NULL
integrin	NULL
-subunit	NULL
(	NULL
CD	NULL
18	NULL
)	NULL
:	NULL
A	NULL
retinoic	NULL
acid-inducible	NULL
gene	NULL
.	NULL

Blood	NULL
79:602	NULL
,	NULL
1992	NULL
44	NULL
.	NULL

Rosmarin	NULL
AG	NULL
,	NULL
Levy	NULL
R	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Cloning	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
CD18	NULL
promoter	NULL
.	NULL

Blood	NULL
79:2598	NULL
,	NULL
1992	NULL
45	NULL
.	NULL

Kozmik	NULL
Z	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Dorfler	NULL
P	NULL
,	NULL
Adams	NULL
B	NULL
,	NULL
Busslinger	NULL
M	NULL
:	NULL
The	NULL
promoter	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:2662	NULL
,	NULL
1992	NULL
46	NULL
.	NULL

Saksela	NULL
K	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
Negative	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
kappa	NULL
light-chain	NULL
gene	NULL
transcription	NULL
by	NULL
a	NULL
short	NULL
sequence	NULL
homologous	NULL
to	NULL
the	NULL
murine	NULL
B1	NULL
repetitive	NULL
element	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:3698	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
--	NULL
The	NULL
promoter	NULL
and	NULL
5°	NULL
flanking	NULL
sequences	NULL
controlling	NULL
human	NULL
B29	NULL
gene	NULL
expression	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
AA	NULL
Thompson	NULL
,	NULL
WJ	NULL
Jr	NULL
Wood	NULL
,	NULL
MJ	NULL
Gilly	NULL
,	NULL
MA	NULL
Damore	NULL
,	NULL
SA	NULL
Omori	NULL
and	NULL
R	NULL
Wall	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/2/666.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

